{"meta":{"query_hash":"5ec910aabd7a","filters":{"venue":"Anti-Cancer Drugs"},"cohort_total":79,"direct_labels_cover":1,"predictions_cover":79,"exported":79,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5ec910aabd7a","api":"https://metacan.xera.ac/api/v1/cohort?venue=Anti-Cancer+Drugs"},"results":[{"id":"W19262372","doi":"10.1097/cad.0b013e328329977f","title":"(Dis)orderly development in the North: Resistance and rule in the Northern Boreal Initiative (Ontario).","year":2005,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Canadian Identity and History","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Resistance (ecology); Boreal; Geography; Ecology; Archaeology; Biology","score_opus":0.016674828828665698,"score_gpt":0.24672583713295526,"score_spread":0.23005100830428957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W19262372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88068366,0.004416131,0.0010790591,0.008795525,0.00022145236,0.00014835599,0.0033557646,0.00016550164,0.10113455],"genre_scores_gemma":[0.8931911,0.002100563,0.0019263122,0.0015026613,0.000041012223,0.000038799684,0.0011995924,0.000051498577,0.09994839],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9996897,0.000021367801,0.000009457123,0.00005855484,0.00009114785,0.00012977041],"domain_scores_gemma":[0.9994505,0.000024559336,0.00013115958,0.000028477189,0.00016305613,0.00020221419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023825098,0.00019298117,0.0001571438,0.0005847218,0.004230631,0.0014096395,0.0004897516,0.00037271535,0.0060037435],"category_scores_gemma":[0.00046912965,0.00015149298,0.00020972066,0.0011294639,0.0014546564,0.00044878744,0.001019296,0.00045685272,0.00066248875],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008007336,0.0001350299,0.6286029,0.00054333353,0.000092005655,0.0073220623,0.039291427,0.00043013634,0.029107384,0.01642705,0.05695216,0.2202957],"study_design_scores_gemma":[0.00001621844,0.00006083496,0.732596,0.00005215791,0.000023654853,0.0008047883,0.01039767,0.00015413447,0.00075826776,0.0005242319,0.2545848,0.00002727366],"about_ca_topic_score_codex":0.96699053,"about_ca_topic_score_gemma":0.9923579,"teacher_disagreement_score":0.03300947,"about_ca_system_score_codex":0.017624993,"about_ca_system_score_gemma":0.015307059,"threshold_uncertainty_score":0.12787884},"labels":[],"label_agreement":null},{"id":"W1963631227","doi":"10.1097/cad.0b013e3282f46aec","title":"A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients","year":2008,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group; Hôpital Saint-François d'Assise","funders":"","keywords":"Gemcitabine; Medicine; Regimen; Internal medicine; Vinorelbine; Oxaliplatin; Refractory (planetary science); Gastroenterology; Chemotherapy; Adverse effect; Oncology; Surgery; Cancer; Colorectal cancer","score_opus":0.02533042115458789,"score_gpt":0.29155552318333233,"score_spread":0.26622510202874444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963631227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989039,0.00070313,0.000044037795,0.000020083024,0.0000051489,0.00003614148,0.0000963952,0.000002332369,0.00018890208],"genre_scores_gemma":[0.99898213,0.00023851014,0.0001038341,0.00008032398,0.0000402454,0.000038387967,0.0004143351,0.0000021075139,0.000100188234],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99942267,0.0003037812,0.00006191438,0.00009158333,0.0000614034,0.00005873083],"domain_scores_gemma":[0.99916315,0.00019809141,0.00026715206,0.000060424547,0.00006867297,0.0002425042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088891765,0.00021474519,0.00053394696,0.0002864392,0.0003393212,0.00047078554,0.00017096274,0.0003006903,0.0010402739],"category_scores_gemma":[0.0014007003,0.00014261423,0.00032616794,0.0003750374,0.00015247073,0.0002724407,0.00019760324,0.00028903905,0.00022508195],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012667461,0.001006371,0.9581199,0.00012496619,0.00034716836,0.00062261435,0.0002624571,0.00015139421,0.0055253943,0.00004464552,0.00030167258,0.020825977],"study_design_scores_gemma":[0.0025226464,0.02337141,0.9653487,0.000037823862,0.00053878565,0.0026895902,0.0002360682,0.00037841336,0.0013498969,0.0000388931,0.0034713396,0.000016533415],"about_ca_topic_score_codex":0.00028619953,"about_ca_topic_score_gemma":0.0004693233,"teacher_disagreement_score":0.0010402739,"about_ca_system_score_codex":0.00025076565,"about_ca_system_score_gemma":0.00027302004,"threshold_uncertainty_score":0.004701078},"labels":[],"label_agreement":null},{"id":"W1963819705","doi":"10.1097/cad.0b013e328341185b","title":"Inhibiting aberrant Stat3 function with molecular therapeutics","year":2010,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Toronto","funders":"","keywords":"STAT3; STAT protein; Cancer research; Downregulation and upregulation; Biology; Multiple myeloma; Signal transduction; Cell biology; Immunology; Gene; Genetics","score_opus":0.04739348485247957,"score_gpt":0.3524562118507138,"score_spread":0.3050627269982342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963819705","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015495773,0.99271566,0.0007798507,0.0003110129,0.00023169674,0.000023838396,0.000059082635,0.00003784366,0.0042914725],"genre_scores_gemma":[0.0057046497,0.98862094,0.0009969721,0.00031157813,0.00012929435,0.000032898115,0.0001462612,0.000005004878,0.004052423],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999936,0.000009211818,0.0000072147955,0.0000123715035,0.000026379783,0.000008837595],"domain_scores_gemma":[0.9999573,0.000012793263,0.000008714976,0.0000019411423,0.0000131991255,0.000005960136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018036649,0.0006858462,0.00086094777,0.0013136087,0.00018447386,0.00045572777,0.0004447658,0.00056666986,0.002915531],"category_scores_gemma":[0.00013030552,0.000159652,0.0003324423,0.0009241412,0.00020871924,0.0005032878,0.00039744002,0.0012861664,0.0022700583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011439115,0.0002536826,0.00015578976,0.005266966,0.00007393597,0.00025726744,0.00003570172,0.0005290291,0.021481944,0.0034171771,0.015292476,0.9531216],"study_design_scores_gemma":[0.000060512753,0.00034077666,0.0011492227,0.00091953954,0.000103520346,0.0023427403,0.000033833407,0.0003395096,0.0087857675,0.0016330796,0.9842672,0.000024471154],"about_ca_topic_score_codex":0.00042436304,"about_ca_topic_score_gemma":0.0011855797,"teacher_disagreement_score":0.002915531,"about_ca_system_score_codex":0.00039825446,"about_ca_system_score_gemma":0.00039130173,"threshold_uncertainty_score":0.009753406},"labels":[],"label_agreement":null},{"id":"W1966425626","doi":"10.1097/00001813-200311000-00001","title":"Doxycycline and other tetracyclines in the treatment of bone metastasis","year":2003,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Bone health and treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; McMaster University","funders":"","keywords":"Doxycycline; Prostate cancer; Cancer research; Medicine; Matrix metalloproteinase; Metastasis; Breast cancer; Tetracycline; Cancer; Cancer cell; Osteoclast; Minocycline; Bone metastasis; Matrix metalloproteinase inhibitor; Oncology; Internal medicine; Biology; Antibiotics; Microbiology","score_opus":0.09369714820908856,"score_gpt":0.4241381933555619,"score_spread":0.3304410451464733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966425626","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0078550875,0.9790371,0.002086396,0.0019847036,0.00095564325,0.000057509616,0.00015373019,0.000073321164,0.007796479],"genre_scores_gemma":[0.102565,0.85741484,0.004849316,0.002319768,0.0012933908,0.00017697878,0.0006843449,0.000042735843,0.030653656],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997943,0.000034445955,0.000021286154,0.00003838248,0.000082290244,0.000029260871],"domain_scores_gemma":[0.9998325,0.00003339712,0.00003869636,0.000009320718,0.000047747366,0.00003826538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030853658,0.00034661757,0.0004797241,0.0010166715,0.0002789366,0.0003356079,0.00032407788,0.00066038355,0.0029280945],"category_scores_gemma":[0.00025888634,0.00010443996,0.00038384576,0.00085068116,0.00030416987,0.0003454343,0.00044540688,0.0013463065,0.0011041036],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007790795,0.00061192596,0.000791823,0.0049649035,0.00010615937,0.00073156133,0.00012826995,0.0007076417,0.10718749,0.007909034,0.03455012,0.841532],"study_design_scores_gemma":[0.00027189523,0.0012626024,0.0044205575,0.00057286955,0.00008604733,0.0027439583,0.00004940571,0.00043479947,0.030143142,0.0016593453,0.9583131,0.00004239538],"about_ca_topic_score_codex":0.0014869665,"about_ca_topic_score_gemma":0.0041601714,"teacher_disagreement_score":0.0029280945,"about_ca_system_score_codex":0.0006512062,"about_ca_system_score_gemma":0.00047860012,"threshold_uncertainty_score":0.009795487},"labels":[],"label_agreement":null},{"id":"W1975493627","doi":"10.1097/cad.0b013e328333d679","title":"Radiation recall dermatitis triggered by multi-targeted tyrosine kinase inhibitors: sunitinib and sorafenib","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Sunitinib; Sorafenib; Platelet-derived growth factor receptor; Cancer research; Medicine; Tyrosine kinase; Vascular endothelial growth factor; Pathophysiology; Receptor tyrosine kinase; Tyrosine-kinase inhibitor; Recall; Cancer; Pharmacology; Internal medicine; Oncology; Receptor; VEGF receptors; Growth factor; Psychology; Hepatocellular carcinoma","score_opus":0.011594659969088232,"score_gpt":0.2769148304306642,"score_spread":0.265320170461576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975493627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98115253,0.0050719725,0.0044397684,0.0006052544,0.00016363015,0.00016971298,0.00006883035,0.00024225509,0.00808609],"genre_scores_gemma":[0.99795914,0.00069896464,0.00038873978,0.00024473757,0.000087898225,0.000014482303,0.000027001624,0.000008145798,0.0005708386],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99941945,0.00017766656,0.00006547461,0.00009012517,0.00009650043,0.00015075432],"domain_scores_gemma":[0.9986884,0.00060977275,0.00035182264,0.00018510937,0.000056047516,0.00010885806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005947265,0.00084326527,0.00088606705,0.0005246919,0.00053746026,0.0007091694,0.000497299,0.0026421994,0.0020028614],"category_scores_gemma":[0.0026896936,0.00040566697,0.0011216112,0.00031919507,0.0005978842,0.00084596575,0.0006476417,0.0015925058,0.00049098395],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014048526,0.00066429464,0.030412886,0.0004069036,0.00021480874,0.9075595,0.0007179964,0.0006949715,0.029031182,0.00069109676,0.0009319714,0.027269514],"study_design_scores_gemma":[0.00015779777,0.0016225183,0.0138619635,0.000028121762,0.00009754188,0.9713939,0.00014024507,0.00070019765,0.009223322,0.00016067235,0.002593462,0.000020155163],"about_ca_topic_score_codex":0.00041668213,"about_ca_topic_score_gemma":0.0004765747,"teacher_disagreement_score":0.0026421994,"about_ca_system_score_codex":0.0005253592,"about_ca_system_score_gemma":0.00023164357,"threshold_uncertainty_score":0.0067002773},"labels":[],"label_agreement":null},{"id":"W1977609704","doi":"10.1097/cad.0b013e32832f4aa8","title":"Methotrexate-induced apoptosis is enhanced by altered expression of methylenetetrahydrofolate reductase","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Methylenetetrahydrofolate reductase; TUNEL assay; Apoptosis; Methotrexate; Terminal deoxynucleotidyl transferase; Hyperhomocysteinemia; Methyltransferase; Pharmacology; Chemistry; Homocysteine; Molecular biology; Biology; Endocrinology; Internal medicine; Cancer research; Methylation; Biochemistry; Medicine; DNA; Genotype","score_opus":0.026803602711573768,"score_gpt":0.35476926397037,"score_spread":0.3279656612587962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977609704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99313027,0.0035859789,0.0017808652,0.000055279805,0.000018913519,0.00001601738,0.0002946526,0.00007125122,0.0010466746],"genre_scores_gemma":[0.9962347,0.0011804156,0.00085476856,0.00003195577,0.000008006568,0.00001980528,0.00031686062,0.0000070280366,0.0013466075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976856,0.000041803767,0.0000288826,0.00004821446,0.00007040866,0.000042110667],"domain_scores_gemma":[0.999808,0.00001971643,0.000093332514,0.000020852842,0.000025811953,0.000032247593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013103368,0.00022384537,0.00023850916,0.00033893614,0.00009243373,0.00020347527,0.00010157383,0.0002721575,0.0010347704],"category_scores_gemma":[0.00015726431,0.00013340157,0.000261426,0.00016911686,0.00011749033,0.00013942958,0.00014837414,0.0003868155,0.00029594186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014658623,0.000013338105,0.0009928803,0.000022459453,0.000006337083,0.000077659155,0.000012589485,0.0000123198,0.99773043,0.000034165743,0.0000140448265,0.00093726517],"study_design_scores_gemma":[0.000028745748,0.0005974921,0.050693244,0.000013774313,0.000039639064,0.0011978812,0.00002921238,0.0005238089,0.94487244,0.000058120197,0.0019404759,0.0000051757866],"about_ca_topic_score_codex":0.00034388324,"about_ca_topic_score_gemma":0.00040416926,"teacher_disagreement_score":0.0010347704,"about_ca_system_score_codex":0.00023477583,"about_ca_system_score_gemma":0.000086948865,"threshold_uncertainty_score":0.003461659},"labels":[],"label_agreement":null},{"id":"W1977936920","doi":"10.1097/00001813-200411000-00005","title":"G2/M blockade by paclitaxel induces caveolin-1 expression in A549 lung cancer cells: caveolin-1 as a marker of cytotoxicity","year":2004,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec; Université Laval","funders":"","keywords":"Paclitaxel; Caveolin 1; A549 cell; Cytotoxicity; Cell cycle; Caveolae; Cytotoxic T cell; Apoptosis; Cancer research; Cell; Lung cancer; Cancer cell; Cell culture; Chemistry; Pharmacology; Cancer; Biology; Cell biology; Medicine; Internal medicine; In vitro; Biochemistry","score_opus":0.005456338230907018,"score_gpt":0.26444046240751806,"score_spread":0.25898412417661104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977936920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567586,0.0016432237,0.0010518372,0.00009778284,0.00002194708,0.000027301865,0.00030465232,0.000059801387,0.0011176654],"genre_scores_gemma":[0.9942741,0.001138443,0.0013082272,0.00007549551,0.000012815358,0.000052446092,0.0006477238,0.000024194427,0.002466508],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988675,0.00002186682,0.000011546809,0.000017189608,0.000023187731,0.00003940715],"domain_scores_gemma":[0.9999336,0.000019249357,0.000011451524,0.000010642871,0.00000912821,0.000015895896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007627859,0.00027533318,0.0003563975,0.0001947849,0.00021815115,0.0002387597,0.00014639484,0.00029728794,0.0008173754],"category_scores_gemma":[0.000082227765,0.00012977999,0.00018771955,0.00019907358,0.00014217106,0.00015949362,0.00015343257,0.00036969638,0.00037049217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056668214,0.000018500083,0.00007754732,0.000013743298,0.0000015959519,0.000029628956,0.0000061430837,0.000025040712,0.9994179,0.0000177871,0.000022483691,0.00031302014],"study_design_scores_gemma":[0.000016466125,0.00025046992,0.0041140164,0.0000022734753,0.0000057995626,0.00013113546,0.000011478668,0.00043801873,0.9942174,0.000018365336,0.0007924357,0.0000020595314],"about_ca_topic_score_codex":0.0015605638,"about_ca_topic_score_gemma":0.0021207863,"teacher_disagreement_score":0.0015605638,"about_ca_system_score_codex":0.00044374267,"about_ca_system_score_gemma":0.0002013936,"threshold_uncertainty_score":0.0032196045},"labels":[],"label_agreement":null},{"id":"W1978585178","doi":"10.1097/00001813-200606000-00014","title":"Improved anti-tumor response rate with decreased cardiotoxicity of non-pegylated liposomal doxorubicin compared with conventional doxorubicin in first-line treatment of metastatic breast cancer in patients who had received prior adjuvant doxorubicin: results of a retrospective analysis","year":2006,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Doxorubicin; Cardiotoxicity; Anthracycline; Internal medicine; Metastatic breast cancer; Cyclophosphamide; Breast cancer; Adjuvant; Randomization; Oncology; Cancer; Chemotherapy; Surgery; Randomized controlled trial; Gastroenterology","score_opus":0.008634561448113807,"score_gpt":0.2784867038953679,"score_spread":0.2698521424472541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978585178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983311,0.0012735554,0.00015226155,0.000012123354,0.0000030711512,0.000014638794,0.000095768315,0.000002519124,0.000114996095],"genre_scores_gemma":[0.9995585,0.00018960777,0.00007357682,0.000016579486,0.000008152771,0.000009317009,0.000111013265,0.0000010776894,0.00003214217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990408,0.00043801742,0.00015127374,0.00017635837,0.00014681094,0.00004673593],"domain_scores_gemma":[0.99702305,0.0010841108,0.0013459232,0.00024511715,0.00015690457,0.00014497938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018185508,0.00015159542,0.00048561272,0.00030904557,0.00008904509,0.0003498576,0.00017399067,0.00028750242,0.00052240206],"category_scores_gemma":[0.003654877,0.00013714681,0.0006303116,0.00035244416,0.0002252782,0.00023187957,0.00012308867,0.00023721965,0.00010558653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026076611,0.00031688655,0.94144815,0.00025951656,0.0013332735,0.0004214041,0.0001296202,0.0005945108,0.0070761084,0.000045000725,0.00012470613,0.02217426],"study_design_scores_gemma":[0.00091158715,0.015823947,0.9746799,0.000022458074,0.0012799088,0.0022504355,0.00006615081,0.00088412594,0.0031347184,0.000034752746,0.0008955836,0.000016520804],"about_ca_topic_score_codex":0.00017958652,"about_ca_topic_score_gemma":0.0002632594,"teacher_disagreement_score":0.0018185508,"about_ca_system_score_codex":0.0002189052,"about_ca_system_score_gemma":0.00014929788,"threshold_uncertainty_score":0.009617567},"labels":[],"label_agreement":null},{"id":"W1984697909","doi":"10.1097/cad.0b013e3282a213ce","title":"Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects","year":2007,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Micropharma (Canada)","funders":"National Institute of Allergy and Infectious Diseases; Korea Research Institute of Standards and Science","keywords":"Doxorubicin; Internalization; Cancer research; Cytotoxicity; In vitro; In vivo; Pharmacology; Cancer cell; Liposome; Chemistry; Medicine; Cancer; Cell; Chemotherapy; Biology; Biochemistry; Internal medicine","score_opus":0.008670695760990747,"score_gpt":0.2795823270588681,"score_spread":0.2709116312978774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984697909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964923,0.0007978185,0.0019104652,0.000022808592,0.0000056094314,0.000018490155,0.00012210685,0.000017133116,0.00061333436],"genre_scores_gemma":[0.9950192,0.0006422258,0.0027092327,0.000014589311,0.000001972749,0.000019694471,0.00026385515,0.000008337907,0.0013207354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991655,0.000016348267,0.000006920695,0.000022159615,0.000019195371,0.000018780633],"domain_scores_gemma":[0.9999652,0.0000124733,0.0000071150266,0.0000031607956,0.000005537844,0.000006579765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013793437,0.00017179729,0.00017669628,0.000078122204,0.000084038664,0.00013495634,0.00010618496,0.00018523123,0.0004981165],"category_scores_gemma":[0.00010613779,0.00008057612,0.00015075834,0.000105673054,0.00011813878,0.00011624145,0.000107487955,0.00022937807,0.00020751514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093214396,0.000016868187,0.0002009648,0.000029133358,0.000002206821,0.000037765065,0.000013762583,0.00012773965,0.99872655,0.0000361595,0.00001076606,0.0007048472],"study_design_scores_gemma":[0.0000065425324,0.00020487909,0.0022177876,0.0000025867173,0.000005543861,0.000118927805,0.000009282971,0.0013069521,0.99569595,0.000008080506,0.0004209131,0.0000024983349],"about_ca_topic_score_codex":0.0013008268,"about_ca_topic_score_gemma":0.0012090742,"teacher_disagreement_score":0.0013008268,"about_ca_system_score_codex":0.00030595416,"about_ca_system_score_gemma":0.00017088337,"threshold_uncertainty_score":0.002586484},"labels":[],"label_agreement":null},{"id":"W1984891600","doi":"10.1097/cad.0b013e328313e172","title":"Interest of liposomal doxorubicin as a radiosensitizer in malignant glioma xenografts","year":2008,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Doxorubicin; Glioma; Radiosensitizer; Biodistribution; Medicine; Chemotherapy; Pharmacology; Cancer research; U87; Radiation therapy; Oncology; Chemistry; Internal medicine; In vitro","score_opus":0.028189836916229755,"score_gpt":0.28970212617144114,"score_spread":0.2615122892552114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984891600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99785393,0.0005998801,0.0010136769,0.000030830517,0.000007039909,0.000019755325,0.00005070969,0.000016575603,0.00040748282],"genre_scores_gemma":[0.99648416,0.00047799898,0.0017847437,0.000013678357,0.000005088093,0.000020781337,0.00017778143,0.000015647176,0.0010201012],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990904,0.000025412672,0.0000059894082,0.000021343038,0.000022543256,0.000015714795],"domain_scores_gemma":[0.9998932,0.000040442963,0.000021285903,0.000013286783,0.000017089895,0.000014726889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019780322,0.00021668326,0.00018129636,0.00015014863,0.0000787885,0.0001786293,0.00010661354,0.00016773253,0.0004121452],"category_scores_gemma":[0.00019228892,0.0000959375,0.00009537989,0.00008544186,0.00013627575,0.00022333585,0.00013755308,0.00025250745,0.00012325135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009517035,0.000028307122,0.00010213862,0.00001306356,0.0000018509666,0.000016640932,0.00001054891,0.00008911221,0.99883705,0.000039642877,0.000012319334,0.00075418636],"study_design_scores_gemma":[0.00001302035,0.00094258453,0.0012342941,0.0000025429824,0.000011144461,0.000069657064,0.000012089043,0.0015772515,0.9954288,0.000014911458,0.0006915013,0.0000021209578],"about_ca_topic_score_codex":0.00069328066,"about_ca_topic_score_gemma":0.0006746372,"teacher_disagreement_score":0.00069328066,"about_ca_system_score_codex":0.00023613739,"about_ca_system_score_gemma":0.000101127625,"threshold_uncertainty_score":0.0017133355},"labels":[],"label_agreement":null},{"id":"W1985842761","doi":"10.1097/cad.0000000000000145","title":"Integrins","year":2014,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"China Scholarship Council; McGill University Health Centre","keywords":"Integrin; Extracellular matrix; Cell biology; Cell adhesion; Signal transduction; Cell surface receptor; Intracellular; Motility; Cell adhesion molecule; Receptor; Cancer research; Cell; Biology; Biochemistry","score_opus":0.0640475224849201,"score_gpt":0.4258113649242002,"score_spread":0.36176384243928006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985842761","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011996877,0.96460587,0.0013071991,0.0010411335,0.0012941791,0.00005694154,0.00041771887,0.00009468204,0.0299826],"genre_scores_gemma":[0.009869201,0.9604179,0.0013221402,0.0012728838,0.0006040313,0.00006729408,0.0011007144,0.000014684709,0.025331091],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997595,0.000032412023,0.000024069395,0.00004147226,0.000104034094,0.00003850117],"domain_scores_gemma":[0.99990535,0.000020105746,0.000015529804,0.0000055851287,0.000038874437,0.000014655894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022965818,0.0009915069,0.00086634164,0.0014704543,0.00038152933,0.0014090475,0.0007353377,0.0012302053,0.016242255],"category_scores_gemma":[0.00043527648,0.00021069434,0.0004953206,0.0013366917,0.0003051214,0.0007837438,0.00055482326,0.0013278193,0.013259276],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012332085,0.00008629165,0.00041129065,0.0075311377,0.00007384401,0.0005895215,0.000102647085,0.0002587571,0.015233467,0.011654957,0.12659767,0.8373372],"study_design_scores_gemma":[0.000013128175,0.00003143713,0.0003011922,0.00052323216,0.000028700726,0.0013892967,0.000026839336,0.0000269784,0.001453763,0.00089469063,0.9953033,0.0000074296668],"about_ca_topic_score_codex":0.00078148855,"about_ca_topic_score_gemma":0.001037097,"teacher_disagreement_score":0.016242255,"about_ca_system_score_codex":0.00052448834,"about_ca_system_score_gemma":0.0006327514,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W1987526635","doi":"10.1097/cad.0b013e3282eea257","title":"Apoptotic pathway induced by noscapine in human myelogenous leukemic cells","year":2007,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; Iran University of Medical Sciences","keywords":"Noscapine; Apoptosis; DNA fragmentation; Phosphatidylserine; Poly ADP ribose polymerase; Chemistry; K562 cells; Caspase; Cell biology; Molecular biology; Programmed cell death; Cancer research; Biology; Biochemistry; Alkaloid; DNA; Polymerase","score_opus":0.008083415128999077,"score_gpt":0.25188574934280084,"score_spread":0.24380233421380176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987526635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795496,0.011186896,0.0028746263,0.0002097706,0.000087381544,0.00018861367,0.0013610426,0.000077248485,0.004464918],"genre_scores_gemma":[0.9926778,0.0028801775,0.0011739788,0.000099634526,0.000024822455,0.000097382195,0.001127184,0.0000047325084,0.00191422],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988484,0.000026548178,0.000010876819,0.000017020933,0.000040776304,0.000019917601],"domain_scores_gemma":[0.99994004,0.0000102662625,0.00001627389,0.000008818796,0.000013568484,0.000010973788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010136154,0.00027724376,0.00020229776,0.00018231357,0.00016818769,0.00018767195,0.00010918046,0.00017834186,0.001366587],"category_scores_gemma":[0.0001020227,0.000059563452,0.00017082505,0.00021996345,0.00014255618,0.00015922224,0.00012634657,0.0003604553,0.00027844956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008033089,0.00013029116,0.0005403664,0.00022822301,0.00001554667,0.0004208518,0.00004977502,0.00011321446,0.9927214,0.00025734594,0.00017069103,0.00454902],"study_design_scores_gemma":[0.0001464861,0.0015309766,0.010728585,0.000019669447,0.000034572942,0.0010878103,0.000058930647,0.00090787286,0.97618586,0.0001525763,0.009138907,0.0000077480345],"about_ca_topic_score_codex":0.0003860231,"about_ca_topic_score_gemma":0.00043018477,"teacher_disagreement_score":0.001366587,"about_ca_system_score_codex":0.00019870984,"about_ca_system_score_gemma":0.00018098754,"threshold_uncertainty_score":0.0045716763},"labels":[],"label_agreement":null},{"id":"W1989545813","doi":"10.1097/01.cad.0000224442.78211.27","title":"Kinamycins A and C, bacterial metabolites that contain an unusual diazo group, as potential new anticancer agents: antiproliferative and cell cycle effects","year":2006,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Manitoba","funders":"National Cancer Institute","keywords":"Topoisomerase; Chinese hamster ovary cell; Cell cycle; Diazo; Cell growth; Biochemistry; Biology; DNA synthesis; DNA gyrase; Cell; Mechanism of action; Chemistry; DNA; In vitro; Receptor","score_opus":0.005652982179236384,"score_gpt":0.2463329000675111,"score_spread":0.24067991788827472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989545813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722911,0.020547435,0.0033905555,0.00012592199,0.000033878903,0.00006966066,0.00029546,0.000101064565,0.0031449215],"genre_scores_gemma":[0.9897893,0.0046366444,0.0038096556,0.00004889794,0.000012286629,0.000034913966,0.00021658954,0.000007160667,0.0014445612],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993587,0.000015538812,0.000007264623,0.000012902759,0.00001644773,0.000011947244],"domain_scores_gemma":[0.9999362,0.000009911704,0.000015928927,0.0000068670706,0.000011320385,0.000019756191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081720835,0.0002983226,0.00021268569,0.00025427926,0.00011029541,0.00017509943,0.0001403196,0.00033684407,0.00061803235],"category_scores_gemma":[0.000076797085,0.000076237506,0.0001246221,0.00018115967,0.00013188469,0.00022410163,0.00012786278,0.0001925902,0.00024778626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015142412,0.000021826469,0.00016570573,0.00009162483,0.000004688684,0.00009739851,0.000010239816,0.00015499744,0.99542576,0.00009706627,0.00002168706,0.003757591],"study_design_scores_gemma":[0.00003474789,0.0010975447,0.0043155644,0.000010235755,0.000021435912,0.0007740447,0.000021629887,0.00043832362,0.98746175,0.000080076505,0.005733228,0.000011486166],"about_ca_topic_score_codex":0.0004502617,"about_ca_topic_score_gemma":0.0009763337,"teacher_disagreement_score":0.00061803235,"about_ca_system_score_codex":0.00028253303,"about_ca_system_score_gemma":0.00016471797,"threshold_uncertainty_score":0.002067566},"labels":[],"label_agreement":null},{"id":"W1999564272","doi":"10.1097/cad.0b013e3283287c20","title":"Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Prodrug; Pharmacokinetics; Pharmacology; Nicotinamide; Bolus (digestion); Therapeutic index; Chemistry; Mechanism of action; Medicine; In vitro; Drug; Internal medicine; Biochemistry; Enzyme","score_opus":0.014539764167131096,"score_gpt":0.30485593516102777,"score_spread":0.29031617099389667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999564272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977047,0.00446721,0.0075767864,0.0004139541,0.00015096068,0.0016036896,0.001940808,0.00028429957,0.0065152794],"genre_scores_gemma":[0.9762464,0.0066110613,0.0056178663,0.0002550026,0.000058448855,0.0011150374,0.0031819004,0.00004668739,0.0068675056],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998821,0.000024437955,0.00000575429,0.000016847956,0.000031216437,0.000039668947],"domain_scores_gemma":[0.9998704,0.000014650281,0.000025557512,0.000013476806,0.000026803667,0.00004910729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046284354,0.00066961715,0.0006473366,0.00032887762,0.00022096718,0.00044181693,0.000728979,0.00060914125,0.0023411068],"category_scores_gemma":[0.00026630086,0.00024955592,0.0003095799,0.00023723456,0.00027982038,0.00037052573,0.00022923357,0.0014777833,0.0006888512],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030756583,0.0053635063,0.0006332886,0.00036185494,0.00010835892,0.00032941738,0.0001076857,0.004300063,0.94959843,0.0010011975,0.0018624149,0.033258114],"study_design_scores_gemma":[0.0028141257,0.118874885,0.004194731,0.00008085524,0.00031148596,0.0007809613,0.00011861896,0.0050532697,0.8396927,0.00055037014,0.027502619,0.00002541274],"about_ca_topic_score_codex":0.0010168594,"about_ca_topic_score_gemma":0.0018512002,"teacher_disagreement_score":0.0023411068,"about_ca_system_score_codex":0.0005698501,"about_ca_system_score_gemma":0.00087488187,"threshold_uncertainty_score":0.007831812},"labels":[],"label_agreement":null},{"id":"W2005482433","doi":"10.1097/cad.0b013e32832cb8bc","title":"Interaction of ionizing radiation and ZRBA1, a mixed EGFR/DNA-targeting molecule","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Clonogenic assay; Ionizing radiation; Comet assay; Cell cycle; Cell cycle checkpoint; Apoptosis; Cancer research; Epidermal growth factor receptor; DNA damage; Tyrosine kinase; Chemistry; DNA repair; Molecular biology; Biology; Irradiation; Signal transduction; Cell biology; Receptor; DNA; Biochemistry","score_opus":0.009402137015691033,"score_gpt":0.26894242854634487,"score_spread":0.25954029153065383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005482433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98911333,0.006078206,0.002540604,0.00009595503,0.000048052032,0.00006612986,0.00019727787,0.000074644944,0.0017856018],"genre_scores_gemma":[0.99293846,0.0022785095,0.0023415484,0.00004866973,0.000019962365,0.000049877388,0.0003555384,0.000007748568,0.0019597355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988854,0.000022039161,0.0000058393844,0.000030072724,0.000025845045,0.000027628726],"domain_scores_gemma":[0.99996066,0.000010571225,0.000012564049,0.0000035924786,0.0000037003708,0.000008978487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012048811,0.00034546424,0.00028925296,0.00022542881,0.00009303418,0.00020517332,0.00024723122,0.00031726217,0.0016662475],"category_scores_gemma":[0.00011715963,0.00016445511,0.0002576775,0.00016442171,0.00009958349,0.000116561896,0.00014702577,0.00031580852,0.000385836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021833502,0.000055297478,0.00030245766,0.00011092404,0.000030777035,0.000039928465,0.000015188935,0.00017399169,0.9952684,0.00012472512,0.00007627988,0.0035837705],"study_design_scores_gemma":[0.000038695798,0.0009257815,0.0027026031,0.000010118025,0.00005249896,0.00021345276,0.000013552177,0.00062116585,0.99113804,0.00001657699,0.004260886,0.0000065374375],"about_ca_topic_score_codex":0.00036338184,"about_ca_topic_score_gemma":0.0004235255,"teacher_disagreement_score":0.0016662475,"about_ca_system_score_codex":0.00020470843,"about_ca_system_score_gemma":0.00013736381,"threshold_uncertainty_score":0.005574167},"labels":[],"label_agreement":null},{"id":"W2006614996","doi":"10.1097/00001813-200010000-00007","title":"Irinotecan-associated pulmonary toxicity","year":2000,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Irinotecan; Interstitial lung disease; Pulmonary toxicity; Pulmonary function testing; Adverse effect; Disease; Lung cancer; Internal medicine; Complication; Pneumonitis; Intensive care medicine; Clinical trial; Colorectal cancer; Cancer; Lung; Surgery","score_opus":0.009231034895599156,"score_gpt":0.2549069427323571,"score_spread":0.24567590783675794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006614996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95426744,0.012003154,0.0031390735,0.0054520494,0.00032320627,0.00020757696,0.00016016427,0.00024219303,0.02420525],"genre_scores_gemma":[0.9931579,0.0025851636,0.0006590108,0.0017221041,0.00035977046,0.000012661093,0.000051427585,0.000009563961,0.0014422996],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9998222,0.000030533178,0.000019088235,0.000031304626,0.00003595136,0.00006091835],"domain_scores_gemma":[0.9994966,0.0001316329,0.0001535514,0.00003584921,0.000041104147,0.00014127913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018808126,0.0005001337,0.0004980089,0.00044617566,0.00096373877,0.00075204455,0.00034723405,0.001609286,0.0016736662],"category_scores_gemma":[0.0009876362,0.00021512904,0.00037293427,0.0003871174,0.0005616043,0.0005114548,0.000541479,0.0013082954,0.00044494114],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012092762,0.00006290585,0.018771078,0.00006598338,0.000013086389,0.9713677,0.0001271264,0.00023101692,0.0022431086,0.00033749922,0.0006142376,0.00604543],"study_design_scores_gemma":[0.0000219475,0.00034291012,0.012701157,0.000027054495,0.000034615176,0.9794068,0.00014483416,0.00049004273,0.0026471114,0.00035552445,0.003817938,0.000010163855],"about_ca_topic_score_codex":0.0011124474,"about_ca_topic_score_gemma":0.0020019333,"teacher_disagreement_score":0.0016736662,"about_ca_system_score_codex":0.00062438723,"about_ca_system_score_gemma":0.00038146952,"threshold_uncertainty_score":0.0055989623},"labels":[],"label_agreement":null},{"id":"W2007222488","doi":"10.1097/00001813-200206000-00010","title":"DNA repair protein levels vis-à-vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program","year":2002,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute","keywords":"DNA repair; Nucleotide excision repair; Cell culture; Mechanism of action; Drug resistance; Cancer research; DNA; Biology; Cancer; Molecular biology; Chemistry; Genetics; In vitro","score_opus":0.024893951936866915,"score_gpt":0.2900982614699908,"score_spread":0.2652043095331239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007222488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954739,0.0008483269,0.000662017,0.000030682942,0.0000048052166,0.000017507375,0.0016180532,0.000047835558,0.0012967864],"genre_scores_gemma":[0.99178255,0.00067140866,0.0011442152,0.000035175468,0.0000031866716,0.000043586537,0.004764654,0.000008572539,0.0015465079],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996989,0.000043041633,0.000035648547,0.00006504009,0.0001229892,0.00003448973],"domain_scores_gemma":[0.9996991,0.00008721699,0.000059023823,0.00004368344,0.00007562997,0.000035393812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021760043,0.00022540023,0.00024069245,0.0009535826,0.00011864884,0.0002950353,0.00012827272,0.0001984287,0.001109566],"category_scores_gemma":[0.00042145877,0.00012614469,0.00015389587,0.00078687374,0.0001125772,0.00012187032,0.00017173751,0.00026922827,0.00040663782],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079668773,0.00025556216,0.14202358,0.00008373612,0.00012881639,0.00014792861,0.00010662685,0.0004719746,0.8390545,0.0001130753,0.00052320486,0.01629421],"study_design_scores_gemma":[0.000013781634,0.00096070406,0.5791175,0.0000065582144,0.00009519591,0.0008869863,0.00010458317,0.0012073399,0.415154,0.00005320892,0.0023893903,0.000010683639],"about_ca_topic_score_codex":0.0014158572,"about_ca_topic_score_gemma":0.0015814247,"teacher_disagreement_score":0.0014158572,"about_ca_system_score_codex":0.0001478145,"about_ca_system_score_gemma":0.00010353068,"threshold_uncertainty_score":0.0037118793},"labels":[],"label_agreement":null},{"id":"W2008582463","doi":"10.1097/01.cad.0000190282.05748.63","title":"Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumors","year":2005,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Gemcitabine; Medicine; Vomiting; Regimen; Nausea; Cisplatin; Doxorubicin; Internal medicine; Toxicity; Gastroenterology; Diarrhea; Chemotherapy; Phases of clinical research; Neutropenia","score_opus":0.008319956625518418,"score_gpt":0.3313097557740054,"score_spread":0.32298979914848697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008582463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899094,0.0027403955,0.0007707359,0.0007973499,0.00018708245,0.0030685412,0.0007448744,0.00010022353,0.0016814828],"genre_scores_gemma":[0.9857649,0.0021166215,0.0027459618,0.0012153906,0.00023944091,0.00372942,0.001925458,0.000028826817,0.0022339216],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999503,0.0002704217,0.000024609348,0.00007040044,0.00005634909,0.00007512563],"domain_scores_gemma":[0.99903667,0.00014125441,0.00014977275,0.000065616834,0.000043005082,0.00056361785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018354259,0.0014239027,0.0024496675,0.00048407534,0.0004676587,0.0008162934,0.00090011087,0.0013568043,0.0025317615],"category_scores_gemma":[0.0010423015,0.0006121997,0.0008213323,0.0005542701,0.00096273015,0.00080916344,0.0004966148,0.0034748325,0.00067916256],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6878177,0.098642044,0.009359163,0.0011343617,0.0012554995,0.0007006665,0.00043537145,0.004277201,0.05164244,0.0007536579,0.007570317,0.13641162],"study_design_scores_gemma":[0.6359124,0.35097873,0.005685037,0.000028344879,0.00021291428,0.0003835415,0.000040284656,0.0011435036,0.002773222,0.00022777879,0.00259685,0.000017365139],"about_ca_topic_score_codex":0.00052414153,"about_ca_topic_score_gemma":0.0014480746,"teacher_disagreement_score":0.0025317615,"about_ca_system_score_codex":0.00092857814,"about_ca_system_score_gemma":0.0017189207,"threshold_uncertainty_score":0.009706736},"labels":[],"label_agreement":null},{"id":"W2010947980","doi":"10.1097/00001813-200203000-00007","title":"The doxorubicin cardioprotective agent dexrazoxane (ICRF-187) induces endopolyploidy in rat neonatal myocytes through inhibition of DNA topoisomerase II","year":2002,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Dexrazoxane; Topoisomerase; Doxorubicin; Myocyte; Cardiotoxicity; Pharmacology; Flow cytometry; Biology; Chemistry; Cell biology; DNA; Molecular biology; Biochemistry; Anthracycline; Chemotherapy","score_opus":0.01661729173243212,"score_gpt":0.2512402859184167,"score_spread":0.23462299418598456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010947980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951715,0.002043159,0.0018193352,0.00006843359,0.000018261415,0.000016019092,0.00013505357,0.00003199078,0.00069628],"genre_scores_gemma":[0.99544334,0.0017662961,0.0012498514,0.000026483338,0.000007692831,0.000022095732,0.00020740763,0.000005689023,0.0012711341],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995077,0.0000090718695,0.0000073791343,0.000011735797,0.000010655413,0.000010414965],"domain_scores_gemma":[0.99993277,0.00001629348,0.000024307259,0.000007681243,0.000005905763,0.0000130004455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008929909,0.0002305331,0.0001516057,0.00011558336,0.00006657987,0.00013413257,0.00011321052,0.00013570041,0.0006807116],"category_scores_gemma":[0.00009662426,0.000092504015,0.00009886722,0.000054434156,0.00014010715,0.00010873265,0.00008067493,0.00039869928,0.00012523633],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049681017,0.000008428493,0.00010644869,0.000013845796,0.0000016989472,0.000024747784,0.0000073806013,0.000022317243,0.99898845,0.00003046928,0.0000068076915,0.00073978916],"study_design_scores_gemma":[0.000013321173,0.0003780334,0.0030352327,0.0000036751574,0.000005319541,0.000106610416,0.000012018311,0.00020196826,0.9956508,0.000010945751,0.00058118557,9.754771e-7],"about_ca_topic_score_codex":0.00037147573,"about_ca_topic_score_gemma":0.0008316586,"teacher_disagreement_score":0.0006807116,"about_ca_system_score_codex":0.00016882847,"about_ca_system_score_gemma":0.000118774726,"threshold_uncertainty_score":0.0022771955},"labels":[],"label_agreement":null},{"id":"W2011397767","doi":"10.1097/00001813-200302000-00001","title":"Neovastat—a novel antiangiogenic drug for cancer therapy","year":2003,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université du Québec à Montréal","funders":"","keywords":"Angiogenesis; Medicine; Drug; Clinical trial; Matrix metalloproteinase; Matrix metalloproteinase inhibitor; Multiple myeloma; Pharmacology; Cancer; Lung cancer; Apoptosis; Cancer research; Vascular endothelial growth factor; Oncology; Internal medicine; Biology; VEGF receptors","score_opus":0.05688579399434322,"score_gpt":0.37250908454387416,"score_spread":0.3156232905495309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011397767","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042944195,0.99496317,0.00049024605,0.0004129816,0.00034719642,0.00001589357,0.000022230499,0.000025626341,0.0032931843],"genre_scores_gemma":[0.0019341958,0.99434173,0.0006151884,0.00037593936,0.00021381173,0.000021718859,0.00005987746,0.0000037367672,0.0024338358],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998858,0.000016914799,0.000011131081,0.000019664894,0.000052651892,0.000013858775],"domain_scores_gemma":[0.99988914,0.000036919795,0.000014899033,0.0000048626493,0.000033319855,0.000020834179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046917167,0.0009355663,0.0010436038,0.0018903031,0.00032627865,0.000797058,0.000978584,0.0011799892,0.0034388506],"category_scores_gemma":[0.00028979426,0.00024431362,0.00034925874,0.0016684477,0.00046937968,0.0012855858,0.00041384323,0.0016808681,0.0034237157],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010844741,0.00016142061,0.00019922483,0.0035883,0.000051132636,0.0004357721,0.000035160378,0.00043010697,0.0048541594,0.0026293756,0.032439154,0.9550677],"study_design_scores_gemma":[0.00005536958,0.00013125196,0.0006080158,0.00055342284,0.00003194933,0.002396903,0.000025638928,0.000124129,0.001136506,0.001069987,0.99385357,0.000013220716],"about_ca_topic_score_codex":0.00075849734,"about_ca_topic_score_gemma":0.001651813,"teacher_disagreement_score":0.0034388506,"about_ca_system_score_codex":0.0006749913,"about_ca_system_score_gemma":0.0007174932,"threshold_uncertainty_score":0.011504114},"labels":[],"label_agreement":null},{"id":"W2011409049","doi":"10.1097/00001813-200602000-00007","title":"The combi-targeting concept: evidence for the formation of a novel inhibitor in vivo","year":2006,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre; McGill University; Royal Victoria Hospital","funders":"","keywords":"In vivo; Chemistry; In vitro; Acetylation; Cmax; Hydrolysis; Epidermal growth factor receptor; High-performance liquid chromatography; Biochemistry; Receptor; Pharmacology; Pharmacokinetics; Chromatography; Biology","score_opus":0.02588368228105015,"score_gpt":0.30137434649294514,"score_spread":0.275490664211895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011409049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9369658,0.010053268,0.04354316,0.00026560997,0.00007386415,0.0002590721,0.0005651348,0.0002723491,0.008001882],"genre_scores_gemma":[0.9831156,0.0015305385,0.01074091,0.00010778028,0.000017659366,0.00006386884,0.0003775732,0.000042960768,0.0040030894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998673,0.00002707354,0.0000074405034,0.000037969174,0.000037095564,0.000023202432],"domain_scores_gemma":[0.9997558,0.000053050357,0.00009817949,0.00002749037,0.000033833214,0.000031566266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002619617,0.00036750195,0.00023992601,0.00013641044,0.000098559976,0.00040024825,0.0002985963,0.000395764,0.0013657166],"category_scores_gemma":[0.0003370831,0.0001567867,0.00016959014,0.00007612171,0.00023657006,0.00036357934,0.00011018283,0.00040618237,0.00052729395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020860483,0.000026257007,0.00021003834,0.000041465,0.000010377565,0.00007885253,0.00001443281,0.00009403237,0.99449843,0.0003391093,0.000058030313,0.00442026],"study_design_scores_gemma":[0.000022931992,0.00050239207,0.0008539251,0.0000019381253,0.000011216351,0.00051923393,0.000004065711,0.00089104293,0.9940328,0.00004643935,0.0031105499,0.0000033929853],"about_ca_topic_score_codex":0.00041297523,"about_ca_topic_score_gemma":0.00031239295,"teacher_disagreement_score":0.0013657166,"about_ca_system_score_codex":0.00031003833,"about_ca_system_score_gemma":0.00017149288,"threshold_uncertainty_score":0.004568815},"labels":[],"label_agreement":null},{"id":"W2011446012","doi":"10.1097/cad.0b013e3280115fe8","title":"Type II combi-molecules: design and binary targeting properties of the novel triazolinium-containing molecules JDD36 and JDE05","year":2006,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Royal Victoria Regional Health Centre; Health Canada; Royal Victoria Hospital","funders":"","keywords":"Epidermal growth factor receptor; Epidermal growth factor; Tyrosine kinase; Biology; Growth factor receptor; Molecular biology; DU145; Comet assay; Receptor; A431 cells; LNCaP; DNA damage; Chemistry; Cancer research; Cell biology; Biochemistry; Cancer cell; Cell; DNA; Cancer; Cell cycle","score_opus":0.018886906288876265,"score_gpt":0.2368112892721645,"score_spread":0.21792438298328823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011446012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98147327,0.003922346,0.010979406,0.00020765979,0.000081917125,0.00023618032,0.00042704132,0.00012442279,0.0025477647],"genre_scores_gemma":[0.97988164,0.0010367763,0.01516909,0.00010212074,0.000018749814,0.00012856,0.00031612866,0.000011643434,0.0033352461],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999255,0.000011921216,0.000008797467,0.00001984984,0.000020821728,0.000013027705],"domain_scores_gemma":[0.999915,0.000010682595,0.000034894583,0.000005619162,0.000013615962,0.000020198939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011543059,0.00021883716,0.00018763597,0.00015260134,0.000057485362,0.00026749147,0.00024695322,0.00024446507,0.0008989585],"category_scores_gemma":[0.00016243782,0.00008374938,0.0001100798,0.00012294474,0.00012437778,0.0001634139,0.0001111943,0.0002488239,0.00028801354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015590468,0.000052769123,0.00022373247,0.0000904524,0.000009673803,0.000051283027,0.000015803313,0.00031494725,0.99211603,0.00033083302,0.00011046794,0.0065281587],"study_design_scores_gemma":[0.00008216148,0.0009047715,0.001126328,0.000003910863,0.000024717603,0.0001971946,0.000008331264,0.0018796435,0.9890099,0.000034586807,0.006716584,0.000011760264],"about_ca_topic_score_codex":0.00014574203,"about_ca_topic_score_gemma":0.00027691404,"teacher_disagreement_score":0.0008989585,"about_ca_system_score_codex":0.00023874806,"about_ca_system_score_gemma":0.00008565846,"threshold_uncertainty_score":0.0030072927},"labels":[],"label_agreement":null},{"id":"W2017047836","doi":"10.1097/00001813-200511000-00002","title":"Prostate secretory protein of 94 amino acids (PSP-94) and its peptide (PCK3145) as potential therapeutic modalities for prostate cancer","year":2005,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Prostate cancer; Medicine; Prostate; In vivo; Cancer; Malignancy; Cancer research; Internal medicine; Endocrinology; Pathology; Biology","score_opus":0.04893492827377968,"score_gpt":0.3765215155615032,"score_spread":0.3275865872877235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017047836","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008336394,0.987938,0.0012339792,0.00020884268,0.00023095534,0.000024880148,0.000053457527,0.000027035569,0.0019464468],"genre_scores_gemma":[0.026086735,0.9692954,0.0019697058,0.00030121798,0.0002240149,0.000042566604,0.0001728013,0.00000666536,0.0019008373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999182,0.000015955857,0.000010168851,0.000013208267,0.000029723336,0.0000127520425],"domain_scores_gemma":[0.99994755,0.00001915619,0.000011477903,0.0000019447755,0.000011947053,0.000007975769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019577135,0.00040520378,0.0006685291,0.0007216938,0.00015024515,0.00043808066,0.00028725612,0.00050967775,0.0011060032],"category_scores_gemma":[0.00011621396,0.0001381264,0.0004203229,0.0005872709,0.00019081299,0.000516628,0.00022598058,0.0006748771,0.00045129904],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005950675,0.0003268986,0.0006565142,0.01754309,0.0002387052,0.0015285834,0.00016288934,0.0017602001,0.21673515,0.0042820433,0.00910481,0.74706596],"study_design_scores_gemma":[0.00011437148,0.0027551253,0.0038462668,0.0010805042,0.00038557293,0.00760946,0.00015769797,0.0007028796,0.046533335,0.0017799601,0.9349698,0.00006499883],"about_ca_topic_score_codex":0.0002517548,"about_ca_topic_score_gemma":0.0005770447,"teacher_disagreement_score":0.0011060032,"about_ca_system_score_codex":0.00020178879,"about_ca_system_score_gemma":0.00029043012,"threshold_uncertainty_score":0.0036998987},"labels":[],"label_agreement":null},{"id":"W2017218408","doi":"10.1097/cad.0b013e328011fd99","title":"An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumors","year":2007,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Capecitabine; Medicine; Neutropenia; Tolerability; Internal medicine; Chemotherapy; Gastroenterology; Cisplatin; Transplantation; Refractory (planetary science); Germ cell tumors; Surgery; Progressive disease; Multicenter trial; Oncology; Adverse effect; Cancer; Randomized controlled trial; Multicenter study","score_opus":0.01958008612328598,"score_gpt":0.3350720642321228,"score_spread":0.31549197810883683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017218408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99169946,0.002807708,0.0005866601,0.000485363,0.00016788709,0.0030084883,0.0003892022,0.00005030818,0.0008049819],"genre_scores_gemma":[0.9874247,0.0019156288,0.002408848,0.0008359334,0.00029384936,0.004121966,0.0013867416,0.000021815516,0.0015905977],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99937207,0.00039223753,0.000029733601,0.0000808099,0.000040384974,0.00008479674],"domain_scores_gemma":[0.99895704,0.00022282185,0.00022143326,0.00007546608,0.000056473687,0.00046689162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020581863,0.0017638786,0.0021491856,0.00048185198,0.0005473765,0.0008060479,0.0008289215,0.0012492822,0.0026316303],"category_scores_gemma":[0.0017275607,0.000540744,0.0008486822,0.00040713238,0.0010017386,0.0009632766,0.00036109606,0.002994773,0.0004941033],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8003589,0.07071261,0.006287158,0.00084228977,0.00084900035,0.00049102504,0.0003712313,0.0019486499,0.028872235,0.0003818622,0.0029248446,0.085960224],"study_design_scores_gemma":[0.7109127,0.28155094,0.004079143,0.000024059807,0.00011826997,0.00016937368,0.000030269879,0.0006869274,0.0012062995,0.00010491617,0.0011023463,0.00001464018],"about_ca_topic_score_codex":0.00053062686,"about_ca_topic_score_gemma":0.0018582977,"teacher_disagreement_score":0.0026316303,"about_ca_system_score_codex":0.00073795056,"about_ca_system_score_gemma":0.0010761957,"threshold_uncertainty_score":0.010884881},"labels":[],"label_agreement":null},{"id":"W2030330520","doi":"10.1097/01.cad.0000132231.28888.fa","title":"2-Pyrrolinodoxorubicin and its peptide-vectorized form bypass multidrug resistance","year":2004,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics","keywords":"Cytotoxicity; Intracellular; P-glycoprotein; Multiple drug resistance; Verapamil; Pharmacology; Doxorubicin; Cell culture; K562 cells; Cytotoxic T cell; Chemistry; Biology; Biochemistry; Cell; In vitro; Chemotherapy; Calcium; Antibiotics","score_opus":0.01199001358614045,"score_gpt":0.26484568961881144,"score_spread":0.252855676032671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030330520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880177,0.002893069,0.006977608,0.000119387645,0.00004770292,0.000115024624,0.0003470213,0.00009718086,0.0013853972],"genre_scores_gemma":[0.98836005,0.0013558822,0.006965386,0.0000370898,0.000009512885,0.00008603348,0.0007283053,0.000029101739,0.0024286292],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986386,0.0000324019,0.000018689097,0.00003294067,0.000029594556,0.000022444761],"domain_scores_gemma":[0.9999454,0.000011903277,0.000019813542,0.000009033024,0.0000054414395,0.00000840604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013629108,0.00035203362,0.00032182198,0.00012705321,0.00007812936,0.00027748148,0.00021058989,0.000305651,0.00082983036],"category_scores_gemma":[0.00011474447,0.00010907546,0.00016467682,0.00012756915,0.00017798427,0.00034791086,0.0001423956,0.00045908074,0.0003208114],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007018889,0.000035404202,0.000083064035,0.000039784496,0.0000042948777,0.000052095485,0.00001124866,0.00009864249,0.99767214,0.00022270466,0.000033723507,0.0016766769],"study_design_scores_gemma":[0.000020630527,0.0004947614,0.00069044624,0.0000025751308,0.0000067050373,0.0003192399,0.000007652282,0.0006022291,0.9942086,0.00004595426,0.0035963606,0.00000483365],"about_ca_topic_score_codex":0.00021887806,"about_ca_topic_score_gemma":0.0002399528,"teacher_disagreement_score":0.00082983036,"about_ca_system_score_codex":0.00019560156,"about_ca_system_score_gemma":0.00015972585,"threshold_uncertainty_score":0.0027760267},"labels":[],"label_agreement":null},{"id":"W2031185392","doi":"10.1097/00001813-200211002-00004","title":"Debate on the conservative and aggressive treatment options for the optimal management of indolent non-Hodgkinʼs lymphoma","year":2002,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Watchful waiting; Rituximab; Chemotherapy; Autologous stem-cell transplantation; Lymphoma; Oncology; Aggressive lymphoma; Non-Hodgkin's lymphoma; Disease; Internal medicine; Clinical trial; Surgery; Intensive care medicine; Cancer","score_opus":0.07813416068665378,"score_gpt":0.3619001896838279,"score_spread":0.2837660289971741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031185392","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017034102,0.22739017,0.0017512224,0.7522002,0.012345029,0.000027110567,0.00009281487,0.000030497951,0.0044596186],"genre_scores_gemma":[0.06558934,0.25382707,0.0067770346,0.5972736,0.073270544,0.00021459736,0.00032311585,0.00015327473,0.0025714196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98985773,0.004681186,0.0016421573,0.0010623495,0.0021635895,0.00059297617],"domain_scores_gemma":[0.9633116,0.022919526,0.0020028264,0.000999248,0.007764679,0.003002063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023677409,0.00056167005,0.0019766516,0.0013453203,0.00245141,0.0048930543,0.0038778472,0.010235643,0.004722435],"category_scores_gemma":[0.050461106,0.0004805184,0.0013117484,0.001232091,0.008109763,0.0088783,0.0024735394,0.024019463,0.0025246704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000396399,0.00017541151,0.0017534028,0.0040528458,0.00023426407,0.0006350631,0.0022827901,0.0005355116,0.0010069122,0.08956262,0.40944543,0.4899193],"study_design_scores_gemma":[0.0002437602,0.00016979594,0.0027003558,0.016736059,0.00024295553,0.002113208,0.0045487895,0.0004920955,0.0005790284,0.114402786,0.8575963,0.00017483617],"about_ca_topic_score_codex":0.0025585275,"about_ca_topic_score_gemma":0.0036143933,"teacher_disagreement_score":0.023677409,"about_ca_system_score_codex":0.0043293512,"about_ca_system_score_gemma":0.0070589078,"threshold_uncertainty_score":0.12521958},"labels":[],"label_agreement":null},{"id":"W2032041633","doi":"10.1097/cad.0b013e32836009d7","title":"Molecular analysis of the inhibitory effect of N-acetyl-L-cysteine on the proliferation and invasiveness of pancreatic cancer cells","year":2013,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Agency of Canada","keywords":"Pancreatic cancer; Apoptosis; Cell growth; Cancer research; Reactive oxygen species; Gemcitabine; Senescence; Intracellular; Cell cycle; Cell culture; Epithelial–mesenchymal transition; Cancer; Cancer cell; Chemistry; Biology; Cell biology; Biochemistry; Metastasis","score_opus":0.006478644655596788,"score_gpt":0.23630804437407688,"score_spread":0.2298293997184801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032041633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98857075,0.003824963,0.003935762,0.00011239489,0.00004186845,0.00005636241,0.00072545593,0.00008079719,0.002651652],"genre_scores_gemma":[0.9868693,0.0029395672,0.0054853777,0.000050960425,0.000013507559,0.000074691045,0.0016026397,0.000011024759,0.0029528234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993443,0.000011406051,0.0000066217003,0.000012618113,0.000021669439,0.00001313298],"domain_scores_gemma":[0.99992335,0.000018690547,0.00001496642,0.000009135762,0.000016028718,0.000017835937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001336631,0.00033310565,0.00020323388,0.00023216361,0.00018035875,0.00010874219,0.00022417748,0.00017378473,0.0011508174],"category_scores_gemma":[0.000080720325,0.000090054775,0.00031803866,0.00021386043,0.00014690288,0.00011553112,0.00006194426,0.00032718104,0.00019906503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048793445,0.00001648486,0.00006933948,0.00003095339,0.000004168363,0.000027887969,0.0000057317784,0.000025419713,0.9992937,0.000033861914,0.000009891723,0.00043379024],"study_design_scores_gemma":[0.0000097460925,0.00037778934,0.006353163,0.0000040903,0.000021687145,0.00020887567,0.000017139184,0.00055058283,0.9911538,0.000026263457,0.0012740799,0.000002851351],"about_ca_topic_score_codex":0.0010083445,"about_ca_topic_score_gemma":0.0012497011,"teacher_disagreement_score":0.0011508174,"about_ca_system_score_codex":0.00022909176,"about_ca_system_score_gemma":0.00020519464,"threshold_uncertainty_score":0.003849864},"labels":[],"label_agreement":null},{"id":"W2036467698","doi":"10.1097/cad.0b013e32835006f5","title":"A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Ginseng Biological Effects and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Vancouver General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Protopanaxadiol; Pharmacokinetics; Pharmacology; Oral administration; Cmax; Prostate cancer; Aglycone; Chemistry; Ginsenoside; Cancer; Medicine; Internal medicine; Stereochemistry; Ginseng; Glycoside","score_opus":0.024887690822894378,"score_gpt":0.28923429671459977,"score_spread":0.2643466058917054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036467698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98583174,0.0034590634,0.008268394,0.00015805037,0.00009134335,0.00025029693,0.0005994835,0.00020693152,0.001134822],"genre_scores_gemma":[0.98012424,0.0040111397,0.0120086055,0.00007529312,0.000062490944,0.00018630482,0.000839158,0.000040735482,0.002652016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999225,0.000010319698,0.0000062533773,0.000022791248,0.000025444951,0.000012724655],"domain_scores_gemma":[0.99993455,0.000008042605,0.000026044874,0.0000071494155,0.000007638726,0.000016594173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011243537,0.0004885787,0.00051953335,0.00031111197,0.00013033807,0.00021912258,0.00032324012,0.00032564034,0.0006764885],"category_scores_gemma":[0.000098210694,0.00012869823,0.0002680314,0.00022533016,0.00019237968,0.00031041895,0.00010963616,0.00072868343,0.00022204067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003017824,0.00026535633,0.000048914913,0.000086517364,0.000013357998,0.000078064186,0.000009979292,0.00016456659,0.99172336,0.00004804284,0.000084759944,0.007175272],"study_design_scores_gemma":[0.00028134085,0.016886255,0.0034067028,0.0000133653075,0.00013767893,0.00075609586,0.000017417524,0.0015993221,0.96975917,0.00004828848,0.0070737344,0.000020486877],"about_ca_topic_score_codex":0.0004362028,"about_ca_topic_score_gemma":0.0008837205,"teacher_disagreement_score":0.0006764885,"about_ca_system_score_codex":0.00022866078,"about_ca_system_score_gemma":0.0002369841,"threshold_uncertainty_score":0.0022630692},"labels":[],"label_agreement":null},{"id":"W2041352031","doi":"10.1097/00001813-200501000-00014","title":"The antitumor anthracyclines doxorubicin and daunorubicin do not inhibit cell growth through the formation of iron-mediated reactive oxygen species","year":2004,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Dexrazoxane; Daunorubicin; Doxorubicin; Anthracycline; Pharmacology; Chemistry; Reactive oxygen species; Biochemistry; Biology; Leukemia; Medicine; Chemotherapy; Internal medicine","score_opus":0.014207030151936237,"score_gpt":0.2608693665313333,"score_spread":0.24666233637939705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041352031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688317,0.011558069,0.008962219,0.00035034868,0.00008802101,0.00014638633,0.001331815,0.00013515186,0.008596262],"genre_scores_gemma":[0.97940534,0.004118773,0.007556166,0.00012603894,0.000017132723,0.00009271071,0.0019638215,0.000021479987,0.0066984184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976045,0.000040302002,0.000032432275,0.000049391005,0.000095113544,0.000022280217],"domain_scores_gemma":[0.9998894,0.000015937601,0.00003754207,0.000024823074,0.000018708834,0.000013634806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011578788,0.00020519267,0.00028843727,0.00013439836,0.00011386357,0.0002284054,0.00019998201,0.00023119918,0.0010804455],"category_scores_gemma":[0.00014638201,0.00011931108,0.00009418415,0.00014838814,0.00016179461,0.00016172211,0.00011932689,0.00030993248,0.00052738795],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049153252,0.00001576951,0.0002868502,0.000055697772,0.0000042308566,0.000031524603,0.000009882924,0.000023214567,0.99733716,0.00012273059,0.000062230116,0.0020015275],"study_design_scores_gemma":[0.000025315247,0.00040186272,0.008317991,0.000010002949,0.000011664236,0.0006486403,0.000024564662,0.00035514473,0.97708374,0.000056150515,0.013060523,0.0000044070243],"about_ca_topic_score_codex":0.00040004816,"about_ca_topic_score_gemma":0.00088191195,"teacher_disagreement_score":0.0010804455,"about_ca_system_score_codex":0.0001803701,"about_ca_system_score_gemma":0.000112249945,"threshold_uncertainty_score":0.0036144853},"labels":[],"label_agreement":null},{"id":"W2055722183","doi":"10.1097/00001813-200503000-00009","title":"Enhancement of antineoplastic action of 5-aza-2???-deoxycytidine by zebularine on L1210 leukemia","year":2005,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Deoxycytidine; Cancer research; Decitabine; In vivo; Leukemia; L1210 cells; DNA methylation; Biology; Molecular biology; Chemistry; In vitro; Cytotoxicity; Gene; Immunology; Cancer; Gene expression; Biochemistry; Gemcitabine; Genetics","score_opus":0.011030437415811993,"score_gpt":0.2846017155389284,"score_spread":0.2735712781231164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055722183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945311,0.0022163386,0.0008216246,0.000046024084,0.00001902434,0.000035871155,0.00019996967,0.000060792478,0.0020693445],"genre_scores_gemma":[0.99615073,0.001295385,0.0010186816,0.000026941749,0.000011010152,0.000030478092,0.00038675228,0.000017002434,0.0010630157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998801,0.000038875347,0.000011905882,0.000016578684,0.000022097272,0.000030452358],"domain_scores_gemma":[0.999912,0.00003000757,0.000015521335,0.00001199047,0.000009297303,0.000021182177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015448588,0.00039212476,0.00037168365,0.00029322773,0.00010682877,0.00021779451,0.00024686023,0.00021163559,0.0010802915],"category_scores_gemma":[0.00016887546,0.00013690404,0.00021829741,0.00017092672,0.00015624674,0.00015222421,0.0002023022,0.00034617374,0.00028533046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002874471,0.00005069897,0.00008938993,0.000033774082,0.000005733657,0.000028204291,0.00001167554,0.00014958381,0.9969716,0.0000372078,0.000025803782,0.002308871],"study_design_scores_gemma":[0.000042569143,0.00090322667,0.0013955468,0.0000038441935,0.000013171055,0.000080857186,0.000006056498,0.00051855756,0.9958818,0.000010823494,0.001140795,0.0000027123867],"about_ca_topic_score_codex":0.00080583635,"about_ca_topic_score_gemma":0.0009749143,"teacher_disagreement_score":0.0010802915,"about_ca_system_score_codex":0.00019543174,"about_ca_system_score_gemma":0.00017034523,"threshold_uncertainty_score":0.0036139488},"labels":[],"label_agreement":null},{"id":"W2057651711","doi":"10.1097/cad.0b013e328350e835","title":"Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Doxorubicin; Cisplatin; Osteosarcoma; Methotrexate; Apoptosis; Cancer research; Chemotherapy; Pharmacology; Combination therapy; Medicine; Cytotoxic T cell; Chemistry; Immunology; In vitro; Internal medicine; Biochemistry","score_opus":0.010772700577210914,"score_gpt":0.25216623206455535,"score_spread":0.24139353148734444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057651711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934528,0.0024075077,0.0030076485,0.00005749322,0.00003074932,0.00004549515,0.00017121635,0.000050551258,0.00077650434],"genre_scores_gemma":[0.9955059,0.0009908732,0.0023945733,0.000036662168,0.000010898632,0.000050888728,0.0002768191,0.000015785685,0.0007175657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998734,0.000025920828,0.000015635622,0.00002779984,0.000032377528,0.000024833946],"domain_scores_gemma":[0.9999231,0.000016969088,0.000022418322,0.000014889155,0.000009403243,0.000013209692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018882805,0.00029676632,0.00030157916,0.0001884836,0.00008855649,0.00012344294,0.00018506174,0.0001465749,0.00076560234],"category_scores_gemma":[0.00010623044,0.00013870317,0.00025181985,0.00015283258,0.00016861063,0.0001675348,0.0001264155,0.0004363296,0.00013919326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011502929,0.000046358946,0.00010156829,0.000027117841,0.0000056149324,0.00001714869,0.0000088806355,0.0000614652,0.9984137,0.000018092323,0.000018029301,0.0011671083],"study_design_scores_gemma":[0.00003411533,0.0009544956,0.0034718,0.0000038741828,0.000013423842,0.00013514099,0.000012527812,0.00071252335,0.9932633,0.000020325202,0.0013745975,0.0000039643205],"about_ca_topic_score_codex":0.0003657697,"about_ca_topic_score_gemma":0.0008084629,"teacher_disagreement_score":0.00076560234,"about_ca_system_score_codex":0.00015187872,"about_ca_system_score_gemma":0.00014341432,"threshold_uncertainty_score":0.002561152},"labels":[],"label_agreement":null},{"id":"W2058098342","doi":"10.1097/00001813-200210000-00004","title":"Epirubicin/docetaxel regimen in progressive breast cancer—a phase II study","year":2002,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"","keywords":"Docetaxel; Epirubicin; Medicine; Regimen; Neutropenia; Metastatic breast cancer; Febrile neutropenia; Internal medicine; Breast cancer; Chemotherapy; Adverse effect; Phases of clinical research; Oncology; Surgery; Gastroenterology; Cancer","score_opus":0.03439308193999131,"score_gpt":0.38094733083647836,"score_spread":0.34655424889648706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058098342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586076,0.0018257218,0.00024715482,0.00012227934,0.00006285116,0.0008557895,0.00022651257,0.00003335658,0.0007656273],"genre_scores_gemma":[0.98841184,0.004174579,0.0013019473,0.00058613607,0.00024478804,0.0013177848,0.0014332801,0.00002097575,0.002508601],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99969196,0.00014163785,0.00001507088,0.00004165881,0.00004768091,0.00006209714],"domain_scores_gemma":[0.9996736,0.00005147281,0.000058556187,0.000030174699,0.00002071005,0.00016552853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009571904,0.00092339923,0.0018228092,0.00035459283,0.00033260015,0.0005642989,0.00062667,0.00064197724,0.002094847],"category_scores_gemma":[0.0004754691,0.00039307072,0.0006934138,0.00037207917,0.00057510455,0.00037951532,0.00019009114,0.002064451,0.0005268056],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3766032,0.2636712,0.014289959,0.0015480092,0.0013240522,0.0011014482,0.00037304626,0.003338559,0.11266627,0.000296921,0.0030899893,0.2216974],"study_design_scores_gemma":[0.20124288,0.76792985,0.018900251,0.000042712953,0.00035313718,0.00081464165,0.00005425811,0.00097310985,0.0057812184,0.00008464185,0.0038014988,0.00002175477],"about_ca_topic_score_codex":0.0008854767,"about_ca_topic_score_gemma":0.002442133,"teacher_disagreement_score":0.002094847,"about_ca_system_score_codex":0.00044977502,"about_ca_system_score_gemma":0.0009885465,"threshold_uncertainty_score":0.007007897},"labels":[],"label_agreement":null},{"id":"W2058595915","doi":"10.1097/00001813-200112004-00003","title":"Maximizing the response to Herceptin® therapy through optimal use and patient selection","year":2001,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Immunohistochemistry; Medicine; Concordance; Oncology; Breast cancer; Trastuzumab; Metastatic breast cancer; Internal medicine; Targeted therapy; Cancer; Disease; Fluorescence in situ hybridization; Gene; Biology","score_opus":0.17277203939993846,"score_gpt":0.44606148375622434,"score_spread":0.2732894443562859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058595915","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8035395,0.026602237,0.08432328,0.019638931,0.0006086049,0.004123423,0.0007455393,0.0009129048,0.059505504],"genre_scores_gemma":[0.9490957,0.00675072,0.032510903,0.0041121533,0.0011054389,0.00142533,0.00074579206,0.00013399079,0.004120028],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99895006,0.0005360066,0.000107485284,0.00009994187,0.00021140449,0.00009509546],"domain_scores_gemma":[0.99922585,0.00028520208,0.0001581518,0.000055687462,0.0000615182,0.00021356552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022888363,0.00039378705,0.00082597625,0.0006193887,0.0002959749,0.0009022695,0.00033968713,0.0006217992,0.0021591298],"category_scores_gemma":[0.002924737,0.0001525353,0.00044030417,0.00037266983,0.00019195258,0.0006746276,0.00062213984,0.00067690125,0.0010366756],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056447024,0.001366627,0.09847193,0.00020807973,0.00011923413,0.0016149502,0.00023135485,0.005994491,0.013935756,0.0015894237,0.01440602,0.8564174],"study_design_scores_gemma":[0.0054702493,0.033283345,0.5262808,0.0013686244,0.0010944082,0.03242407,0.0008624601,0.054508056,0.047603965,0.021182846,0.27555445,0.00036675675],"about_ca_topic_score_codex":0.000108351865,"about_ca_topic_score_gemma":0.00018954926,"teacher_disagreement_score":0.0022888363,"about_ca_system_score_codex":0.0003520026,"about_ca_system_score_gemma":0.00056415156,"threshold_uncertainty_score":0.0121046305},"labels":[],"label_agreement":null},{"id":"W2062087170","doi":"10.1097/00001813-200411000-00003","title":"Peptide-vector strategy bypasses P-glycoprotein efflux, and enhances brain transport and solubility of paclitaxel","year":2004,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics","keywords":"Efflux; P-glycoprotein; Paclitaxel; Peptide; Solubility; Glycoprotein; Chemistry; Vector (molecular biology); Biophysics; Pharmacology; Biochemistry; Internal medicine; Biology; Medicine; Organic chemistry; Multiple drug resistance; Chemotherapy","score_opus":0.01104076863687449,"score_gpt":0.27050389775520434,"score_spread":0.25946312911832986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062087170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99081963,0.0007829215,0.006804687,0.00016160985,0.000043598156,0.000059208953,0.00014669163,0.000109213426,0.0010723176],"genre_scores_gemma":[0.9873511,0.0011411022,0.008473715,0.000064010484,0.000023831584,0.000061855644,0.00036744305,0.000069730064,0.0024472924],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987125,0.000023718485,0.000013722481,0.000029729596,0.000031521442,0.000030123443],"domain_scores_gemma":[0.999899,0.000021786533,0.000034221786,0.000010394451,0.0000119056995,0.000022681972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014250929,0.00051587826,0.00036533654,0.00023745795,0.00016124494,0.0003822839,0.00026021074,0.0003707054,0.0011604495],"category_scores_gemma":[0.00016019701,0.00014498385,0.00017647201,0.00019896693,0.00033604636,0.0005140633,0.00013551742,0.0006933791,0.00033153614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000983715,0.00004443348,0.000049016915,0.000028229988,0.0000050826065,0.00004212707,0.000010988162,0.000063926214,0.99778384,0.00027912212,0.00004612365,0.0015487304],"study_design_scores_gemma":[0.000028411658,0.0004318712,0.00036060106,0.000002140741,0.000014956194,0.0002263237,0.000006699242,0.0005250238,0.99695194,0.00004828144,0.0014003379,0.000003428658],"about_ca_topic_score_codex":0.00062836736,"about_ca_topic_score_gemma":0.0007912657,"teacher_disagreement_score":0.0011604495,"about_ca_system_score_codex":0.00029289327,"about_ca_system_score_gemma":0.00034654932,"threshold_uncertainty_score":0.0038820505},"labels":[],"label_agreement":null},{"id":"W2062392807","doi":"10.1097/cad.0b013e32835a56bc","title":"Peg-filgrastim and cabazitaxel in prostate cancer patients","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University","keywords":"Cabazitaxel; Febrile neutropenia; Medicine; Neutropenia; Filgrastim; Internal medicine; Prostate cancer; Docetaxel; Surgery; Oncology; Cancer; Chemotherapy","score_opus":0.011565426539610167,"score_gpt":0.29568560696011625,"score_spread":0.2841201804205061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062392807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991067,0.00056729367,0.000020970849,0.000056256744,0.0000043687355,0.000004961732,0.00006799294,0.0000015295551,0.0001698886],"genre_scores_gemma":[0.9995522,0.00018617578,0.00004010648,0.00004781426,0.00001532614,0.000004011476,0.00010549563,6.6491674e-7,0.00004817503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968374,0.00010508855,0.00002592931,0.00005669751,0.000062335035,0.00006621174],"domain_scores_gemma":[0.999121,0.00021772913,0.00040213126,0.000030630046,0.00003956005,0.00018898999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035585245,0.00013469768,0.00035874895,0.00041071794,0.0002936367,0.00045480183,0.0002247189,0.0004153142,0.0008508141],"category_scores_gemma":[0.0015246556,0.00014272647,0.00032257795,0.0006856008,0.00017383811,0.00028647855,0.0002113283,0.0004158512,0.00012216817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082679046,0.000063013664,0.9945857,0.0000157455,0.000047339116,0.0003038304,0.0000407921,0.00008679696,0.0004110312,0.000015154955,0.00009565966,0.0035082034],"study_design_scores_gemma":[0.000033940803,0.0007400261,0.9970091,0.000008057651,0.00004740941,0.0012865651,0.000076928336,0.0002937451,0.00012754164,0.000022756287,0.0003493343,0.0000045767288],"about_ca_topic_score_codex":0.0022536628,"about_ca_topic_score_gemma":0.0035888266,"teacher_disagreement_score":0.0022536628,"about_ca_system_score_codex":0.00037427468,"about_ca_system_score_gemma":0.0005288976,"threshold_uncertainty_score":0.004481077},"labels":[],"label_agreement":null},{"id":"W2062686953","doi":"10.1097/00001813-200504000-00009","title":"In vivo efficacy and toxicity of intratumorally delivered mitomycin C and its combination with doxorubicin using microsphere formulations","year":2005,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Doxorubicin; Toxicity; Mitomycin C; Microsphere; In vivo; Therapeutic index; Pharmacology; Chemotherapy; Medicine; Dextran; Chemistry; Surgery; Drug; Internal medicine; Biology; Chromatography","score_opus":0.01139503563033102,"score_gpt":0.2569178602094529,"score_spread":0.2455228245791219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062686953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941018,0.0022196767,0.0024992677,0.00007094409,0.000052730124,0.000079557634,0.00017007359,0.00006729091,0.00073859934],"genre_scores_gemma":[0.9928207,0.0016244713,0.003363722,0.000031411364,0.000045071753,0.00011695417,0.00028230276,0.000033002187,0.0016823839],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975437,0.00006179122,0.000020393378,0.00005271269,0.00005075299,0.00005999901],"domain_scores_gemma":[0.9998185,0.000051724313,0.000048879632,0.00002028397,0.000019418976,0.00004123818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048527442,0.0005967137,0.00053529,0.0004566098,0.00016001808,0.00025489996,0.0002844591,0.0004697418,0.00064530416],"category_scores_gemma":[0.00023361981,0.00018425798,0.00029329312,0.00033278126,0.00026738568,0.0002794032,0.00011569693,0.0005927899,0.00016602218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007758077,0.00028697343,0.0001734848,0.000050678947,0.0000149825255,0.000040239276,0.000022857042,0.00024360068,0.9962567,0.000044211483,0.000045092507,0.0020454074],"study_design_scores_gemma":[0.000059220107,0.0061385264,0.0011866407,0.000004152471,0.00004431229,0.000095864634,0.000007630887,0.0011391724,0.99076337,0.0000139649055,0.00053984503,0.000007421446],"about_ca_topic_score_codex":0.00086265424,"about_ca_topic_score_gemma":0.0011345262,"teacher_disagreement_score":0.00086265424,"about_ca_system_score_codex":0.00033493445,"about_ca_system_score_gemma":0.00041328318,"threshold_uncertainty_score":0.0025663972},"labels":[],"label_agreement":null},{"id":"W2064652673","doi":"10.1097/cad.0b013e32831c14ec","title":"Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Canadian Institutes of Health Research","keywords":"Doxycycline; Cancer research; Internal medicine; Adenocarcinoma; Human breast; Medicine; Oncology; Breast cancer; Biology; Antibiotics; Cancer; Microbiology","score_opus":0.015914708741084173,"score_gpt":0.2997624907008337,"score_spread":0.2838477819597495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064652673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831839,0.010973141,0.0012918167,0.00022947512,0.00009025445,0.00006461961,0.001254616,0.000048049387,0.0028641354],"genre_scores_gemma":[0.98903275,0.0043512783,0.0026394885,0.00010957149,0.000021676306,0.00008502965,0.0012524896,0.000014589191,0.0024930974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99961334,0.0000842136,0.000044890883,0.00006251769,0.000118961536,0.00007610373],"domain_scores_gemma":[0.9998652,0.00004431271,0.000020655292,0.000014187918,0.00003376065,0.00002192858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019194599,0.00027997224,0.0008028016,0.00024178703,0.00022492513,0.0003453072,0.00013882741,0.00023560891,0.00086989475],"category_scores_gemma":[0.00018763347,0.00018325612,0.00028279336,0.00044672907,0.000093213996,0.00015423067,0.0001489184,0.00047749258,0.00030715304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003456425,0.00013167139,0.0007448209,0.00014816162,0.000022241768,0.00008037152,0.000056175184,0.00032558668,0.99397635,0.000080766695,0.00026400175,0.0038241684],"study_design_scores_gemma":[0.00002602891,0.00082993624,0.008702068,0.000013316638,0.000030853993,0.00015891767,0.000060839273,0.001888819,0.98320955,0.000020394331,0.0050486713,0.000010769003],"about_ca_topic_score_codex":0.0048365216,"about_ca_topic_score_gemma":0.008305855,"teacher_disagreement_score":0.0048365216,"about_ca_system_score_codex":0.0005214834,"about_ca_system_score_gemma":0.0003781244,"threshold_uncertainty_score":0.009616733},"labels":[],"label_agreement":null},{"id":"W2069327639","doi":"10.1097/cad.0b013e328327994e","title":"Tranilast inhibits the growth and metastasis of mammary carcinoma","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Tranilast; Mammary carcinoma; Metastasis; Carcinoma; Cancer research; Internal medicine; Medicine; Oncology; Cancer","score_opus":0.0076221064644514626,"score_gpt":0.2393057148340062,"score_spread":0.23168360836955473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069327639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99269533,0.0034143105,0.0006315152,0.00014310959,0.00005414176,0.00005334229,0.0002717305,0.00012090982,0.0026155182],"genre_scores_gemma":[0.991734,0.00351787,0.00073134905,0.000099419405,0.00002694775,0.000047847836,0.0005837583,0.000015730286,0.0032429858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999205,0.000013199923,0.0000053717185,0.000009633684,0.000020960666,0.00003033946],"domain_scores_gemma":[0.9999511,0.000008506094,0.000014022679,0.000004686177,0.0000055441496,0.000016071393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088233566,0.00060495874,0.0003145891,0.0003831869,0.00013608954,0.00015770565,0.00019683244,0.00022697714,0.0018941091],"category_scores_gemma":[0.00008289311,0.000115145966,0.00029809566,0.00016693652,0.00012514977,0.0001912773,0.000147571,0.0006894535,0.00029560688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025470825,0.00020247146,0.00015543863,0.00006441096,0.000008167261,0.000060080976,0.0000130219905,0.00011538666,0.9937122,0.000062032086,0.00010311913,0.005248999],"study_design_scores_gemma":[0.00009334933,0.0036165342,0.004273552,0.00000998618,0.00003482223,0.00035881996,0.000029264089,0.0011872355,0.98759264,0.000052499432,0.0027449364,0.000006314129],"about_ca_topic_score_codex":0.00090726395,"about_ca_topic_score_gemma":0.0017506501,"teacher_disagreement_score":0.0018941091,"about_ca_system_score_codex":0.00019945603,"about_ca_system_score_gemma":0.00023329149,"threshold_uncertainty_score":0.0063364506},"labels":[],"label_agreement":null},{"id":"W2069340479","doi":"10.1097/cad.0b013e3280262427","title":"Gene expression profiles as biomarkers for the prediction of chemotherapy drug response in human tumour cells","year":2007,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Laurentian University; Sudbury Regional Hospital","funders":"","keywords":"Gene expression profiling; Biology; Vinca; Gene; Gene expression; Topoisomerase; Computational biology; Drug; Microarray; Microarray analysis techniques; Cancer research; Pharmacology; Genetics; DNA","score_opus":0.03234895651611599,"score_gpt":0.3474229593625183,"score_spread":0.31507400284640236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069340479","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011130319,0.9921103,0.0032361138,0.00037194905,0.00025196452,0.000023566525,0.00018518236,0.000048976995,0.0026589304],"genre_scores_gemma":[0.004515443,0.9881809,0.0042738062,0.00025247605,0.0001507924,0.000040025916,0.00032347845,0.000008059924,0.0022549834],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996731,0.00006365395,0.000035183268,0.000069193695,0.00013818356,0.000020642208],"domain_scores_gemma":[0.99968016,0.00012895359,0.00004907585,0.000012502323,0.00011205349,0.000017301236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008224016,0.0009680945,0.0021663618,0.0029425747,0.00018969136,0.0010897419,0.0008365247,0.00079723,0.0014524292],"category_scores_gemma":[0.00059543597,0.00030982558,0.00048060794,0.0034681286,0.0004566577,0.0008293324,0.00034357977,0.0011790403,0.0027476782],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011938415,0.00007831562,0.00205006,0.005728281,0.00011925159,0.0002454084,0.00006430797,0.00070595567,0.017473636,0.0033337288,0.012185228,0.9578966],"study_design_scores_gemma":[0.000036438694,0.00023499154,0.012186365,0.0026142888,0.0003045082,0.00396175,0.00020973678,0.0012996285,0.016028248,0.005391575,0.9576416,0.0000909938],"about_ca_topic_score_codex":0.001122005,"about_ca_topic_score_gemma":0.0014416531,"teacher_disagreement_score":0.0029425747,"about_ca_system_score_codex":0.0007155815,"about_ca_system_score_gemma":0.00059501984,"threshold_uncertainty_score":0.005191922},"labels":[],"label_agreement":null},{"id":"W2073605475","doi":"10.1097/cad.0b013e32832ae55f","title":"The marine alkaloid naamidine A promotes caspase-dependent apoptosis in tumor cells","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Marine Sponges and Natural Products","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute","keywords":"Apoptosis; Annexin; Caspase; Programmed cell death; Cancer cell; Cell biology; Biology; Cancer research; Chemistry; Cancer; Biochemistry","score_opus":0.005415570056929603,"score_gpt":0.23955643825708597,"score_spread":0.23414086820015637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073605475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838488,0.0057603857,0.0050708223,0.00015000583,0.000043734777,0.000046923207,0.00029032756,0.000112159476,0.004676814],"genre_scores_gemma":[0.9930582,0.002311326,0.0019826565,0.00004139342,0.000009689077,0.000015656127,0.0002111736,0.0000061679752,0.0023637493],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999441,0.000012609466,0.0000069526122,0.000012278488,0.000017159407,0.000006970166],"domain_scores_gemma":[0.99993503,0.000013759421,0.000017159055,0.000008771103,0.000012006812,0.000013250388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063653286,0.00018943634,0.00010536304,0.00013983034,0.00009770524,0.00015641876,0.00012448872,0.0001640756,0.0010290522],"category_scores_gemma":[0.00010260731,0.00005522946,0.00014357016,0.000102259284,0.00014405367,0.00020264505,0.00013370886,0.0002470187,0.00032324597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012379067,0.000021870446,0.00013894658,0.00005144624,0.000002790847,0.00008569194,0.000008519761,0.00005561381,0.99774253,0.0000637441,0.000023246626,0.0016819265],"study_design_scores_gemma":[0.000036746645,0.00055482524,0.004799005,0.000008738379,0.000010368179,0.00050497253,0.00003404345,0.0011652632,0.9891958,0.00010778697,0.0035777844,0.0000045924344],"about_ca_topic_score_codex":0.0006436197,"about_ca_topic_score_gemma":0.00093530864,"teacher_disagreement_score":0.0010290522,"about_ca_system_score_codex":0.00022211521,"about_ca_system_score_gemma":0.00019050957,"threshold_uncertainty_score":0.0034425259},"labels":[],"label_agreement":null},{"id":"W2074635429","doi":"10.1097/cad.0b013e32831fb500","title":"Sorafenib tosylate in advanced kidney cancer: past, present and future","year":2009,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Sorafenib; Medicine; Sunitinib; Kidney cancer; Oncology; Internal medicine; Cancer; Pharmacology; Clinical trial; Population; Hepatocellular carcinoma","score_opus":0.026817686603057903,"score_gpt":0.3380587351365086,"score_spread":0.3112410485334507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074635429","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010907415,0.9994948,0.000023305203,0.0000926481,0.00004440004,0.0000019642202,0.0000041708604,0.0000015792771,0.00022806835],"genre_scores_gemma":[0.00066224847,0.99899,0.0000765181,0.00007084263,0.00005832404,0.0000028981447,0.000007765415,4.588138e-7,0.00013096543],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997993,0.000055363897,0.000047946098,0.00002901656,0.000053785436,0.000014609854],"domain_scores_gemma":[0.99954337,0.00022134231,0.00011249715,0.000009087738,0.000085797095,0.000027881055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065262365,0.00053616875,0.001321707,0.0030140537,0.00019427539,0.000729186,0.0005525998,0.0006887547,0.0023194419],"category_scores_gemma":[0.00074368867,0.00023713779,0.00047403434,0.003723341,0.0003025563,0.001310129,0.00036565555,0.0006545812,0.0007236087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001467676,0.000058605532,0.00023077833,0.051870745,0.00015397389,0.0003389502,0.000094704184,0.0003227585,0.0012492622,0.0011950954,0.012332587,0.9320057],"study_design_scores_gemma":[0.00009504112,0.00040208822,0.0030398865,0.018406501,0.000674381,0.004591162,0.00025390796,0.0002560588,0.00087607687,0.0016763968,0.9696928,0.00003567953],"about_ca_topic_score_codex":0.0014981884,"about_ca_topic_score_gemma":0.0033986208,"teacher_disagreement_score":0.0030140537,"about_ca_system_score_codex":0.00048564997,"about_ca_system_score_gemma":0.0012171019,"threshold_uncertainty_score":0.0077593327},"labels":[],"label_agreement":null},{"id":"W2075303283","doi":"10.1097/cad.0b013e3280bad82d","title":"Recombinant prostate-specific antigen proaerolysin shows selective protease sensitivity and cell cytotoxicity","year":2007,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Furin; Recombinant DNA; Prostate cancer; Antigen; Proteases; Prostate; Prostate-specific antigen; Molecular biology; Biology; Chemistry; Cancer research; Biochemistry; Immunology; Cancer; Enzyme; Gene","score_opus":0.01737186353691626,"score_gpt":0.27205147427805304,"score_spread":0.25467961074113676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075303283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994728,0.0011238538,0.0030373947,0.000051077688,0.000012797473,0.00001946445,0.0002831741,0.000048477217,0.0006956937],"genre_scores_gemma":[0.9950388,0.0003540414,0.0023390804,0.00001922876,0.0000036969989,0.000010748447,0.0008454191,0.000015013539,0.0013739954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998598,0.000032836495,0.000015457143,0.000022393056,0.000044485358,0.00002500946],"domain_scores_gemma":[0.99986374,0.000038365677,0.000033444918,0.000022086988,0.000020097354,0.000022183396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013918211,0.00019711941,0.00019921978,0.000107057815,0.0000652892,0.00017335544,0.00010738182,0.00016884503,0.00059875834],"category_scores_gemma":[0.00014137926,0.00008825755,0.00018674141,0.00013493242,0.00012604464,0.00010545088,0.00012111683,0.0002854488,0.00023159786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035150522,0.000009417723,0.00010672772,0.000009789483,0.000002416847,0.000019745881,0.0000037748946,0.00003864696,0.9994392,0.000024152332,0.000010752956,0.00030025849],"study_design_scores_gemma":[0.00000578433,0.00021114452,0.0017950648,0.000001335296,0.0000063824114,0.0002845623,0.0000053855506,0.00038524787,0.99649113,0.000014321135,0.0007973421,0.0000021106237],"about_ca_topic_score_codex":0.0005883028,"about_ca_topic_score_gemma":0.00056326285,"teacher_disagreement_score":0.00059875834,"about_ca_system_score_codex":0.00018575919,"about_ca_system_score_gemma":0.00012191775,"threshold_uncertainty_score":0.0020030737},"labels":[],"label_agreement":null},{"id":"W2076804008","doi":"10.1097/cad.0b013e328011a532","title":"Safety and efficacy of pegfilgrastim in children with cancer receiving myelosuppressive chemotherapy","year":2007,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Pegfilgrastim; Medicine; Filgrastim; Neutropenia; Febrile neutropenia; Chemotherapy; Absolute neutrophil count; Internal medicine; Surgery","score_opus":0.007428577568633091,"score_gpt":0.28579257432618876,"score_spread":0.2783639967575557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076804008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819833,0.0013558712,0.00007937152,0.000026640646,0.0000028116012,0.0000095082505,0.0000745657,0.0000047569847,0.00024814377],"genre_scores_gemma":[0.9988212,0.0007070089,0.00017575687,0.000033558536,0.00001420951,0.000014017819,0.0001868834,0.0000025423217,0.00004479328],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99947697,0.00018473137,0.0000621384,0.00006523547,0.00014317976,0.0000676574],"domain_scores_gemma":[0.997663,0.0005976593,0.0013342154,0.00006894389,0.0001443259,0.00019189528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055177213,0.00017633542,0.0004712963,0.00038473323,0.00023222427,0.00042095268,0.0001532957,0.00023651525,0.00038926068],"category_scores_gemma":[0.002828616,0.00011463107,0.00027246357,0.0005686079,0.00035689867,0.00023812857,0.00015178997,0.0003475013,0.00010276623],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017998717,0.00010735734,0.9722739,0.00007339926,0.000060695438,0.0009287951,0.00019208218,0.00022562362,0.003472566,0.000039229573,0.00014441425,0.020682173],"study_design_scores_gemma":[0.00013001752,0.0065934747,0.97801733,0.000051174375,0.0001302804,0.0074232956,0.0002567068,0.00042283576,0.0046853647,0.000040034603,0.002239355,0.000010142121],"about_ca_topic_score_codex":0.0008044331,"about_ca_topic_score_gemma":0.00082803454,"teacher_disagreement_score":0.0008044331,"about_ca_system_score_codex":0.0005324688,"about_ca_system_score_gemma":0.00048595233,"threshold_uncertainty_score":0.0038633347},"labels":[],"label_agreement":null},{"id":"W2078410820","doi":"10.1097/cad.0000000000000043","title":"Jadomycins are cytotoxic to ABCB1-, ABCC1-, and ABCG2-overexpressing MCF7 breast cancer cells","year":2013,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"ABCC1; Abcg2; Cytotoxicity; Efflux; Multiple drug resistance; SKBR3; Cytotoxic T cell; Viability assay; Pharmacology; ATP-binding cassette transporter; Biology; Cancer research; Cancer cell; Transporter; Cancer; Drug resistance; Apoptosis; In vitro; Biochemistry; Microbiology","score_opus":0.008272261964458742,"score_gpt":0.2499829644748366,"score_spread":0.24171070251037785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078410820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987061,0.007677442,0.0013925286,0.00016603546,0.00005028684,0.00003719259,0.0009135448,0.000084395906,0.0026176206],"genre_scores_gemma":[0.99127275,0.0025801274,0.0018788117,0.00012361057,0.000012724265,0.000034051445,0.0017874312,0.000018583693,0.0022919127],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988127,0.000030633248,0.000013879306,0.000015403335,0.000035440356,0.000023422346],"domain_scores_gemma":[0.99991155,0.000018437358,0.000019203295,0.000013991387,0.000015017742,0.00002184077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010422655,0.0002315517,0.00024868446,0.0001987972,0.00012556875,0.00017948124,0.00012842951,0.00021957685,0.00074917724],"category_scores_gemma":[0.00011853644,0.00009165459,0.00017520013,0.0002299143,0.00011763876,0.00010884054,0.00012533095,0.00037686003,0.0002955195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013456307,0.000021546934,0.00015895905,0.000041857187,0.000004390691,0.000041049163,0.000009388288,0.00003277778,0.99801683,0.00002518914,0.0000660997,0.0014472248],"study_design_scores_gemma":[0.00002146356,0.00041364698,0.004809396,0.000008443847,0.000012675981,0.0002979149,0.00003511971,0.0003602155,0.98899007,0.000023019265,0.0050235568,0.0000044135154],"about_ca_topic_score_codex":0.00084617216,"about_ca_topic_score_gemma":0.0012181712,"teacher_disagreement_score":0.00084617216,"about_ca_system_score_codex":0.0001546129,"about_ca_system_score_gemma":0.00012231494,"threshold_uncertainty_score":0.0025061965},"labels":[],"label_agreement":null},{"id":"W2080071903","doi":"10.1097/01.cad.0000203388.68034.06","title":"Inhibition of MMP-9 secretion by the anti-metastatic PSP94-derived peptide PCK3145 requires cell surface laminin receptor signaling","year":2006,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Centre Hospitalier Universitaire Sainte-Justine; Université du Québec à Montréal","funders":"","keywords":"Laminin; MAPK/ERK pathway; Protein kinase A; Biology; Molecular biology; Cell growth; Cell adhesion; Cell biology; Cell surface receptor; Kinase; Extracellular; Extracellular matrix; Cell; Biochemistry","score_opus":0.008405670631498089,"score_gpt":0.23132277821791158,"score_spread":0.2229171075864135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080071903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495995,0.001006176,0.0019387568,0.000084760475,0.0000320584,0.000054860186,0.00043694518,0.00007398977,0.0014125258],"genre_scores_gemma":[0.9921651,0.00095163885,0.0026201322,0.000049405913,0.000011396329,0.000073583215,0.0012879346,0.000015474918,0.0028253503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997639,0.000028743589,0.00002423548,0.000035619367,0.0000748385,0.000072723815],"domain_scores_gemma":[0.99990594,0.000020216832,0.000023653438,0.00001186328,0.000010106783,0.000028211005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012368166,0.00042138106,0.00034757933,0.00015361689,0.00016573998,0.000274557,0.00019213276,0.00025758415,0.0015185399],"category_scores_gemma":[0.00010969337,0.00016939573,0.0003144092,0.00024776923,0.00021149882,0.0001481396,0.00018241513,0.0007539751,0.00048490733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008551961,0.000054917535,0.00006160458,0.000025553863,0.0000027734447,0.00003076933,0.0000058058076,0.000047832134,0.9989766,0.000038058155,0.000028764922,0.00064178143],"study_design_scores_gemma":[0.000022193502,0.00034541875,0.0020308564,0.0000026590367,0.0000059547237,0.000103599246,0.000008142054,0.0006283082,0.9960897,0.000015487665,0.00074571284,0.0000019681686],"about_ca_topic_score_codex":0.00047989772,"about_ca_topic_score_gemma":0.00068563543,"teacher_disagreement_score":0.0015185399,"about_ca_system_score_codex":0.00034225037,"about_ca_system_score_gemma":0.00033458692,"threshold_uncertainty_score":0.0050800443},"labels":[],"label_agreement":null},{"id":"W2087125925","doi":"10.1097/cad.0b013e3283349994","title":"Docetaxel, ifosfamide and cisplatin in solid tumour treatment: a phase I study","year":2010,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ifosfamide; Docetaxel; Mesna; Cisplatin; Medicine; Nitrogen mustard; Chemotherapy; Toxicity; Pharmacology; Urology; Oncology; Anesthesia; Surgery; Internal medicine; Cyclophosphamide","score_opus":0.01912291119158156,"score_gpt":0.36763053314770044,"score_spread":0.3485076219561189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087125925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9671459,0.018323611,0.0012082123,0.0008641761,0.00035526816,0.0068411585,0.0015659845,0.00015879312,0.0035369874],"genre_scores_gemma":[0.9388991,0.031829707,0.0042202855,0.002238862,0.0005770828,0.00890154,0.0068511725,0.00012409338,0.0063581513],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99908924,0.00037953362,0.000058527592,0.00015844146,0.00013898943,0.00017533437],"domain_scores_gemma":[0.9987412,0.00013372536,0.0001794998,0.00009798879,0.00008338175,0.0007642092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019658566,0.0018281005,0.0043155258,0.0008255584,0.000743525,0.0019274618,0.0015280108,0.0022055244,0.0031773853],"category_scores_gemma":[0.0010349719,0.0008794499,0.0018711078,0.0012963747,0.0013344378,0.00096443866,0.0005241408,0.0036232,0.0011592093],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4127763,0.2407869,0.0064166375,0.0042181443,0.0026149,0.0016951697,0.0008152645,0.007805004,0.10550067,0.0009982138,0.011229418,0.20514347],"study_design_scores_gemma":[0.33675924,0.63615143,0.00717858,0.00012824337,0.0007045402,0.00096738705,0.0000638344,0.0009956044,0.0072366903,0.00024349385,0.009511647,0.000059374815],"about_ca_topic_score_codex":0.0013970141,"about_ca_topic_score_gemma":0.0032538646,"teacher_disagreement_score":0.0043155258,"about_ca_system_score_codex":0.0014364498,"about_ca_system_score_gemma":0.0036506718,"threshold_uncertainty_score":0.010629356},"labels":[],"label_agreement":null},{"id":"W2088169167","doi":"10.1097/cad.0b013e328331178f","title":"Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut National Du Cancer; Institute of Cancer Research; Institut National de la Santé et de la Recherche Médicale","keywords":"Docetaxel; Medicine; Internal medicine; Oncology; Hazard ratio; Breast cancer; Chemotherapy; Metastatic breast cancer; Trastuzumab; Univariate analysis; Cancer; Proportional hazards model; Confidence interval; Multivariate analysis","score_opus":0.014285805433521878,"score_gpt":0.33397448165097277,"score_spread":0.3196886762174509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088169167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99948716,0.00018883907,0.000051666506,0.000014316081,0.000004152457,0.000008599185,0.00014085995,0.000001249821,0.0001030923],"genre_scores_gemma":[0.99918264,0.00016627276,0.00006736234,0.00002605519,0.00001451298,0.00001276117,0.00038884522,0.0000022051165,0.00013939379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996581,0.00007012508,0.00003303811,0.000100858655,0.00006290337,0.00007498639],"domain_scores_gemma":[0.9990233,0.00019334366,0.00032131284,0.0001519834,0.00008253634,0.00022749644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000505604,0.00029286058,0.00049982726,0.00050916936,0.00059767906,0.0008408565,0.0002529947,0.00043178463,0.0008396687],"category_scores_gemma":[0.0015828484,0.00043652908,0.0005932395,0.0007394923,0.0002595576,0.00050322764,0.00032556494,0.00073924917,0.00029332278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004040744,0.00012011218,0.99742836,0.0000061041173,0.000058435868,0.00034498525,0.00009510358,0.000037150938,0.0003059404,0.00001078024,0.00007221422,0.00111677],"study_design_scores_gemma":[0.00007852085,0.0011959762,0.9948655,0.000009835161,0.000084368,0.0023317744,0.00031113817,0.00034306847,0.00020011666,0.000030011815,0.0005366307,0.000013156659],"about_ca_topic_score_codex":0.00374837,"about_ca_topic_score_gemma":0.0037212525,"teacher_disagreement_score":0.00374837,"about_ca_system_score_codex":0.00037847008,"about_ca_system_score_gemma":0.0004488146,"threshold_uncertainty_score":0.007453084},"labels":[],"label_agreement":null},{"id":"W2093477091","doi":"10.1097/00001813-200402000-00010","title":"Evaluation of antineoplastic action of 5-aza-2???-deoxycytidine (Dacogen) and docetaxel (Taxotere) on human breast, lung and prostate carcinoma cell lines","year":2004,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Docetaxel; Cancer research; Carcinoma; Oncology; Breast carcinoma; Clonogenic assay; Medicine; Internal medicine; Biology; Cancer; Cell culture; Breast cancer","score_opus":0.03415982134665608,"score_gpt":0.3221899053774003,"score_spread":0.2880300840307442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093477091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99148387,0.00480911,0.0008327854,0.00006430404,0.00004425651,0.00007816302,0.00073175045,0.000031079067,0.0019246459],"genre_scores_gemma":[0.9883118,0.0044387435,0.0025347886,0.000033120145,0.000018758552,0.0000806988,0.0013932165,0.000013648985,0.003175228],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997689,0.00008280094,0.000021260052,0.000027541533,0.00006170926,0.000037810394],"domain_scores_gemma":[0.9998267,0.00006650709,0.000020287578,0.000020826363,0.000036195368,0.000029430159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027878906,0.00027065072,0.0004901315,0.00029995388,0.00016431544,0.00023602598,0.00016891089,0.0002179476,0.0015014668],"category_scores_gemma":[0.00017810785,0.0001792355,0.00023484186,0.00030731384,0.00013948942,0.00012037487,0.000084711704,0.00032657335,0.00023191363],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050220237,0.00017110049,0.0005542913,0.00009757365,0.000017915272,0.00005312622,0.000037699374,0.00023676471,0.99398744,0.00007784444,0.000073483374,0.0041905837],"study_design_scores_gemma":[0.0000555936,0.0023120623,0.0049107857,0.0000055940754,0.00003271912,0.00019772015,0.00002742193,0.000687381,0.98942673,0.0000108176555,0.0023292485,0.00000412462],"about_ca_topic_score_codex":0.0019803066,"about_ca_topic_score_gemma":0.0039812317,"teacher_disagreement_score":0.0019803066,"about_ca_system_score_codex":0.00026982342,"about_ca_system_score_gemma":0.00029442555,"threshold_uncertainty_score":0.005022943},"labels":[],"label_agreement":null},{"id":"W2315916150","doi":"10.1097/00001813-200209000-00013","title":"Antineoplastic action of 5-aza-2′-deoxycytidine and phenylbutyrate on human lung carcinoma cells","year":2002,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Cancer research; Clonogenic assay; Histone deacetylase; Acetylation; Phenylbutyrate; Histone; Carcinogenesis; DNA methylation; Chemistry; Trichostatin A; Gene silencing; Lung cancer; Biology; Molecular biology; DNA; Cell; Gene expression; Biochemistry; Gene; Medicine; Internal medicine","score_opus":0.030471060557525152,"score_gpt":0.29639497834369294,"score_spread":0.2659239177861678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315916150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97148275,0.020562513,0.0017024094,0.00017333917,0.00016378555,0.00013941096,0.0009201993,0.000085308275,0.0047702678],"genre_scores_gemma":[0.9821094,0.009269128,0.0028649522,0.00007909748,0.000031324726,0.00011372823,0.0011172164,0.00001383778,0.0044012587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997856,0.00006268543,0.00001984835,0.000035508587,0.000055829827,0.000040572733],"domain_scores_gemma":[0.9999212,0.000025015099,0.00001062332,0.000012354426,0.000016122278,0.00001467593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020494533,0.0003807104,0.0005967265,0.00022005534,0.00016275347,0.00017621425,0.00026801252,0.00026706947,0.0015893747],"category_scores_gemma":[0.00009274877,0.0001900917,0.0002910136,0.00024270329,0.00011546978,0.00012845952,0.00012478538,0.00042728445,0.0004615137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043483186,0.0001252207,0.00024995502,0.00009982589,0.000012861238,0.00006293053,0.000019132347,0.00014184359,0.9944612,0.000045908324,0.00007083395,0.0042755776],"study_design_scores_gemma":[0.00004768628,0.0015645014,0.0033654936,0.000009238978,0.000024660358,0.00015142707,0.000017857064,0.00051047985,0.9913118,0.000008255995,0.002984823,0.0000037438297],"about_ca_topic_score_codex":0.0022245115,"about_ca_topic_score_gemma":0.0035503984,"teacher_disagreement_score":0.0022245115,"about_ca_system_score_codex":0.00020884603,"about_ca_system_score_gemma":0.00030641977,"threshold_uncertainty_score":0.0053170323},"labels":[],"label_agreement":null},{"id":"W2316570582","doi":"10.1097/cad.0b013e32835cbde7","title":"Preventing MEK1 activation influences the responses of human osteosarcoma cells to bone morphogenetic proteins 2 and 9","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Polytechnique Montréal; Université de Sherbrooke","funders":"","keywords":"Bone morphogenetic protein; Phosphorylation; Osteosarcoma; MAPK/ERK pathway; p38 mitogen-activated protein kinases; Chemistry; Kinase; Protein kinase A; Bone morphogenetic protein 2; SMAD; Cell biology; Bone morphogenetic protein 7; Cancer research; Mitogen-activated protein kinase; Molecular biology; Biology; Biochemistry; In vitro","score_opus":0.015435058045119032,"score_gpt":0.2940673297100402,"score_spread":0.27863227166492116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316570582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99655056,0.001072378,0.000764838,0.00006666924,0.000039710412,0.000034336063,0.00015846292,0.000028768774,0.001284315],"genre_scores_gemma":[0.99453557,0.00096538616,0.0013169008,0.000048811653,0.000010382586,0.00005926574,0.00045556927,0.000008603666,0.002599442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981576,0.00003337319,0.000017932576,0.000025182328,0.000038922186,0.000068862675],"domain_scores_gemma":[0.9999418,0.00001704419,0.000009357133,0.0000053727763,0.00000954488,0.000016920892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015146047,0.0002965655,0.0002484844,0.00021926261,0.00016798286,0.00022874035,0.00012569166,0.0001555948,0.0018209224],"category_scores_gemma":[0.00012720353,0.00018882354,0.00029201913,0.00011344199,0.0001515892,0.00010466088,0.00017478499,0.00035647993,0.00036759867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002642627,0.00010283734,0.00018376815,0.000041526157,0.000003835196,0.00003768598,0.000030220546,0.000051534702,0.99816364,0.000059972423,0.00005627358,0.001004534],"study_design_scores_gemma":[0.000030362247,0.00064185547,0.0029884046,0.000004986841,0.000010547884,0.000106762855,0.000048693953,0.0009671117,0.9924204,0.000026951613,0.0027494528,0.0000043908103],"about_ca_topic_score_codex":0.001517432,"about_ca_topic_score_gemma":0.0022125852,"teacher_disagreement_score":0.0018209224,"about_ca_system_score_codex":0.00021001762,"about_ca_system_score_gemma":0.00026991448,"threshold_uncertainty_score":0.0060915947},"labels":[],"label_agreement":null},{"id":"W2320715667","doi":"10.1097/cad.0b013e32835c3561","title":"Influence of statistician involvement on reporting of randomized clinical trials in medical oncology","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Clinical Oncology Group; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Statistician; Randomized controlled trial; Medicine; Clinical trial; Quality (philosophy); Research design; MEDLINE; Family medicine; Medical physics; Internal medicine; Statistics; Pathology; Mathematics","score_opus":0.8004655031878927,"score_gpt":0.6628950613416558,"score_spread":0.1375704418462369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320715667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30567506,0.11073971,0.23365964,0.24257249,0.013813178,0.031247113,0.0045289397,0.0028323897,0.054931473],"genre_scores_gemma":[0.83929706,0.012273977,0.093887836,0.028180039,0.0039374246,0.017837176,0.0011916722,0.0009366656,0.0024580774],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.034552656,0.7359883,0.17263484,0.011246844,0.04305471,0.0025225827],"domain_scores_gemma":[0.008753944,0.7657491,0.14286406,0.039512932,0.040092114,0.0030279476],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.83900917,0.0018669482,0.0037941278,0.009978613,0.0032254725,0.011695055,0.0062047513,0.0062000137,0.0060544624],"category_scores_gemma":[0.9463189,0.0033700254,0.0047014193,0.01484598,0.008344845,0.01240176,0.009404222,0.007953404,0.0016792606],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02545746,0.001198537,0.33680344,0.04414746,0.0072675943,0.001858719,0.062318508,0.0045797103,0.003612332,0.013861726,0.03797998,0.46091464],"study_design_scores_gemma":[0.016904738,0.016493427,0.40780577,0.11291624,0.0100873485,0.006740069,0.027564451,0.040374085,0.01966818,0.041821036,0.29744092,0.0021837167],"about_ca_topic_score_codex":0.0059998888,"about_ca_topic_score_gemma":0.0058259857,"teacher_disagreement_score":0.16099083,"about_ca_system_score_codex":0.016672231,"about_ca_system_score_gemma":0.03734418,"threshold_uncertainty_score":0.19853044},"labels":[],"label_agreement":null},{"id":"W2322915138","doi":"10.1097/cad.0b013e328351aa8c","title":"Biological evaluation of a new family of aminosteroids that display a selective toxicity for various malignant cell lines","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Plant biochemistry and biosynthesis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Genome Canada","funders":"Canadian Institutes of Health Research; Health Canada; Cancer Research Society; Centre Hospitalier Universitaire de Québec; Cancer Research Institute","keywords":"Apoptosis; Cell culture; Cell growth; Cell cycle; Toxicity; LNCaP; Cell; Chemistry; Pharmacology; Cancer research; Biology; Cancer cell; Cancer; Biochemistry; Internal medicine; Medicine; Genetics","score_opus":0.04863013082892121,"score_gpt":0.29937959059144725,"score_spread":0.25074945976252605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322915138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883044,0.008185414,0.0017148482,0.000048191643,0.000017897913,0.00006570635,0.000289881,0.00004212078,0.0013315115],"genre_scores_gemma":[0.9844642,0.0069587547,0.00488916,0.00006493805,0.000020724196,0.00007534613,0.00095509115,0.000019370167,0.002552281],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999176,0.000019637933,0.000008468939,0.000018599296,0.000023052886,0.00001270496],"domain_scores_gemma":[0.9998355,0.000043232736,0.000026610514,0.000021888774,0.000040652416,0.000032102787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017228597,0.00032423766,0.0003229746,0.00044499605,0.0001507204,0.00016394375,0.00016286371,0.00025004678,0.0009007324],"category_scores_gemma":[0.00016939524,0.00008976353,0.00024908787,0.00024303327,0.00013599094,0.00016915523,0.00012691783,0.00027084688,0.00025160096],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019768269,0.000058353253,0.0003861042,0.000087919405,0.000013872966,0.00009128746,0.000024150344,0.00022997973,0.9930315,0.000038081467,0.000024345329,0.005816723],"study_design_scores_gemma":[0.00003409347,0.0030436458,0.0036765689,0.000012378009,0.000073804105,0.00068997557,0.00004649948,0.0002796807,0.9862482,0.00002458053,0.005860806,0.000009724435],"about_ca_topic_score_codex":0.00037841,"about_ca_topic_score_gemma":0.000918867,"teacher_disagreement_score":0.0009007324,"about_ca_system_score_codex":0.0001571083,"about_ca_system_score_gemma":0.00014783339,"threshold_uncertainty_score":0.0030133128},"labels":[],"label_agreement":null},{"id":"W2324427724","doi":"10.1097/cad.0b013e328351c101","title":"Enhancement of the cytotoxic potential of the mixed EGFR and DNA-targeting ‘combi-molecule’ ZRBA1 against human solid tumour cells by a bis-quinazoline-based drug design approach","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Quinazolinone synthesis and applications","field":"Chemistry","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University; Royal Victoria Regional Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Quinazoline; Chemistry; Cytotoxic T cell; Apoptosis; Epidermal growth factor receptor; Tyrosine kinase; DNA; Flow cytometry; Molecular biology; Cancer research; Biology; Biochemistry; In vitro; Signal transduction; Receptor; Stereochemistry","score_opus":0.010916177647213534,"score_gpt":0.23779933724543956,"score_spread":0.22688315959822603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324427724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99010533,0.0024623605,0.005458679,0.00009787361,0.000017091916,0.00009003771,0.00016275977,0.00007115998,0.0015347688],"genre_scores_gemma":[0.9928351,0.0008519313,0.004960557,0.000029582723,0.0000040978957,0.00003769548,0.00012822435,0.0000055749183,0.0011470594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999951,0.000007700842,0.000003585995,0.000012975859,0.000012599095,0.00001208812],"domain_scores_gemma":[0.99996865,0.0000043522105,0.000011387496,0.000002234714,0.0000064877563,0.0000069183034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009808734,0.00026533045,0.0001579886,0.00020162185,0.000054219625,0.00025489094,0.00024528857,0.00023708376,0.00071077235],"category_scores_gemma":[0.00007660005,0.000108710265,0.00013264063,0.00009023839,0.000086567066,0.00014800519,0.00009915131,0.00020650259,0.00020631347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006874193,0.000045992536,0.000066338864,0.000049725808,0.000005351149,0.000030253592,0.00000774075,0.0004119339,0.99558914,0.00014543482,0.000032830227,0.0035465453],"study_design_scores_gemma":[0.00003856736,0.0009788251,0.00084306,0.0000040656437,0.000018023535,0.00015471276,0.0000068514023,0.002011177,0.9932336,0.000019005318,0.0026855604,0.0000064238116],"about_ca_topic_score_codex":0.00031402186,"about_ca_topic_score_gemma":0.0006423352,"teacher_disagreement_score":0.00071077235,"about_ca_system_score_codex":0.00026307724,"about_ca_system_score_gemma":0.00010605331,"threshold_uncertainty_score":0.002377808},"labels":[],"label_agreement":null},{"id":"W2325764269","doi":"10.1097/00001813-200303000-00008","title":"Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer","year":2003,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Doxorubicin; Pharmacokinetics; Metastatic breast cancer; Liposome; Medicine; Breast cancer; Pharmacology; Cyclophosphamide; Cancer; Chemotherapy; Chemistry; Internal medicine; Biochemistry","score_opus":0.013141340336735861,"score_gpt":0.2877310070471609,"score_spread":0.27458966671042506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325764269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905866,0.0005376161,0.00014063154,0.0000374896,0.0000055580394,0.000012611608,0.000023184353,0.000011563529,0.00017273183],"genre_scores_gemma":[0.99936384,0.00015851205,0.00018771194,0.000050827308,0.000016320639,0.000014682543,0.000058005327,0.0000028731413,0.00014717753],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99979573,0.000079974634,0.000011112643,0.00004510301,0.000039666735,0.000028416693],"domain_scores_gemma":[0.9995764,0.00011882493,0.00013523699,0.000028284074,0.000022060034,0.00011921561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025997244,0.00024957923,0.0006791092,0.00016734976,0.00012539023,0.00041892985,0.00012992734,0.0003499108,0.00042684967],"category_scores_gemma":[0.0013343253,0.00025279264,0.00019961224,0.0001804881,0.00032778239,0.00027925032,0.00013962649,0.00057096564,0.00017039753],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20944448,0.005257959,0.19702713,0.00024466426,0.00079385843,0.0012266462,0.00091209257,0.005579255,0.39926872,0.0002684514,0.0016067654,0.17837001],"study_design_scores_gemma":[0.013118598,0.27882594,0.61201596,0.000041500487,0.00082588656,0.0037319665,0.0002981975,0.015269651,0.07076695,0.00026002302,0.0047425823,0.00010276849],"about_ca_topic_score_codex":0.00044917324,"about_ca_topic_score_gemma":0.0005342988,"teacher_disagreement_score":0.0006791092,"about_ca_system_score_codex":0.0004704103,"about_ca_system_score_gemma":0.00026598977,"threshold_uncertainty_score":0.0034131408},"labels":[],"label_agreement":null},{"id":"W2326174046","doi":"10.1097/cad.0000000000000212","title":"Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals","year":2015,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Medical Research Group","funders":"Genentech","keywords":"Erlotinib; Ranitidine; Pharmacology; Cmax; Pharmacokinetics; Medicine; Omeprazole; Erlotinib Hydrochloride; Tolerability; Proton-pump inhibitor; Gastroenterology; Internal medicine; Epidermal growth factor receptor; Adverse effect; Cancer","score_opus":0.023990155459102155,"score_gpt":0.39359497066074256,"score_spread":0.3696048152016404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326174046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753857,0.0015476301,0.00021565886,0.000031894673,0.000013230652,0.000024295774,0.00008895657,0.000011378895,0.0005283131],"genre_scores_gemma":[0.9991264,0.00031169396,0.00018720292,0.0000713596,0.000017549437,0.000014881592,0.0000821333,0.0000035455791,0.00018538385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996649,0.00013684295,0.000020507827,0.0000787475,0.00006510851,0.000033918204],"domain_scores_gemma":[0.99957067,0.00016030134,0.00012101783,0.000035555502,0.000035602126,0.00007676233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050199137,0.00023819058,0.0005163678,0.00016103321,0.00016907348,0.00030146964,0.00009804619,0.00041336243,0.00089067646],"category_scores_gemma":[0.0010309475,0.00015503366,0.00026928243,0.00012405714,0.00017269634,0.00025940992,0.00015440857,0.00030876874,0.00014212809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12998492,0.0032808965,0.52117366,0.0004691958,0.0014134187,0.0022079581,0.00040422182,0.0010507278,0.23588261,0.00015344929,0.00081481773,0.10316416],"study_design_scores_gemma":[0.00085805357,0.040452383,0.93647426,0.000020942223,0.0005693113,0.0020353124,0.00018636447,0.0010753534,0.016839752,0.0000999535,0.001366409,0.000021950003],"about_ca_topic_score_codex":0.00034699365,"about_ca_topic_score_gemma":0.0004500446,"teacher_disagreement_score":0.00089067646,"about_ca_system_score_codex":0.00014566757,"about_ca_system_score_gemma":0.000108809734,"threshold_uncertainty_score":0.0029795766},"labels":[],"label_agreement":null},{"id":"W2326269621","doi":"10.1097/00001813-200007000-00004","title":"Differential impact of Raf-1 kinase activity on tumor cell resistance to paclitaxel and docetaxel","year":2000,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Cancer Foundation","funders":"","keywords":"Docetaxel; Taxane; Paclitaxel; Cytotoxicity; Kinase; Ovarian cancer; Cancer research; Medicine; Pharmacology; Oncology; Chemotherapy; Internal medicine; Chemistry; Cancer; In vitro; Breast cancer; Biochemistry","score_opus":0.012873713282393347,"score_gpt":0.3305387008184631,"score_spread":0.31766498753606975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326269621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984049,0.00055417937,0.00015259843,0.00002812367,0.0000053839735,0.000007068075,0.00006966313,0.000005748321,0.0007724269],"genre_scores_gemma":[0.9989095,0.00031853747,0.00015113433,0.00001485576,0.0000025384543,0.0000076004567,0.00012296406,0.0000034154727,0.00046950084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977297,0.00006497101,0.000018476025,0.000021725487,0.00006700357,0.00005483676],"domain_scores_gemma":[0.99984705,0.000056594392,0.000020343092,0.000018889632,0.000022934515,0.000034167737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013271693,0.00010505875,0.0002081977,0.00021233798,0.0001409066,0.00038284552,0.000089172805,0.00015414259,0.00087846915],"category_scores_gemma":[0.00036405848,0.00009575225,0.00015277184,0.00016377735,0.00015601612,0.0001571438,0.000093429175,0.0003284017,0.00016761103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007754904,0.00011396036,0.0022156157,0.000027349417,0.000014802781,0.000103803264,0.00004840337,0.0005083223,0.99143255,0.0002703374,0.000079545855,0.004409786],"study_design_scores_gemma":[0.00006417413,0.0020578813,0.03734565,0.00000821957,0.000040182666,0.0010444247,0.000101963975,0.0023394083,0.9544336,0.00012250856,0.0024312858,0.000010739824],"about_ca_topic_score_codex":0.00055598817,"about_ca_topic_score_gemma":0.0010910243,"teacher_disagreement_score":0.00087846915,"about_ca_system_score_codex":0.0003803821,"about_ca_system_score_gemma":0.00017028708,"threshold_uncertainty_score":0.002938807},"labels":[],"label_agreement":null},{"id":"W2326953798","doi":"10.1097/00001813-200304000-00005","title":"Up-regulation of caveolin expression by cytotoxic agents in drug-sensitive cancer cells","year":2003,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut Universitaire de Cardiologie et de Pneumologie de Québec","funders":"","keywords":"Cytotoxic T cell; Etoposide; Caveolin 1; Cancer cell; Drug; Doxorubicin; Drug resistance; Multiple drug resistance; Cancer; Biology; Cancer research; Cell culture; Pharmacology; Chemistry; Cell biology; In vitro; Chemotherapy; Biochemistry; Genetics","score_opus":0.00914706126737542,"score_gpt":0.26331468070040104,"score_spread":0.2541676194330256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326953798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952127,0.00219066,0.00089807465,0.000072435774,0.000018447576,0.000018234567,0.00030781634,0.000048203783,0.001233478],"genre_scores_gemma":[0.9949155,0.0011539216,0.0011405853,0.00005516285,0.000011242317,0.000030085714,0.00054710713,0.000015517579,0.0021308388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998708,0.00002132509,0.00001575208,0.00002326573,0.000039827137,0.00002911885],"domain_scores_gemma":[0.9998808,0.0000322192,0.000024210543,0.00002389797,0.000015488467,0.000023327037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083201965,0.0001872419,0.0002924574,0.00024435882,0.0001698439,0.0003079042,0.00009864507,0.00021254175,0.0008225827],"category_scores_gemma":[0.00012622518,0.00015957636,0.00017922779,0.00023175201,0.00016431513,0.00021801349,0.00019277669,0.00032687644,0.0002803478],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000340726,0.000007966084,0.00010045409,0.000012028462,0.000001562075,0.00004243778,0.00001003136,0.000015720769,0.9993717,0.000024109233,0.000013973529,0.00036597293],"study_design_scores_gemma":[0.0000060842626,0.00013198824,0.00844796,0.000002801109,0.000008056488,0.00024149995,0.000022215949,0.00022000693,0.9894349,0.000019886198,0.0014608833,0.000003705562],"about_ca_topic_score_codex":0.00086115167,"about_ca_topic_score_gemma":0.0012358722,"teacher_disagreement_score":0.00086115167,"about_ca_system_score_codex":0.00033001835,"about_ca_system_score_gemma":0.00012516446,"threshold_uncertainty_score":0.0027517676},"labels":[],"label_agreement":null},{"id":"W2327085958","doi":"10.1097/00001813-200008000-00012","title":"Cost-utility analysis of second-line hormonal therapy in advanced breast cancer: a comparison of two aromatase inhibitors to megestrol acetate","year":2000,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Letrozole; Anastrozole; Megestrol acetate; Medicine; Megestrol; Aromatase; Randomized controlled trial; Oncology; Hormonal therapy; Internal medicine; Quality-adjusted life year; Breast cancer; Quality of life (healthcare); Clinical trial; Aromatase inhibitor; Cancer; Gynecology; Cost effectiveness","score_opus":0.03360241873040829,"score_gpt":0.39322030578894535,"score_spread":0.35961788705853703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327085958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97410643,0.0034186505,0.017213933,0.00091310096,0.00008751723,0.00087385665,0.0012077269,0.000060129005,0.0021187],"genre_scores_gemma":[0.9951219,0.0005978186,0.0030662229,0.00012118665,0.000013800838,0.00028600133,0.00038023386,0.0000062474624,0.00040654856],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9930218,0.006161867,0.0001448679,0.00017729386,0.00022337107,0.00027077072],"domain_scores_gemma":[0.9747161,0.023137718,0.0009769647,0.00030384804,0.00045948822,0.0004058225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010198387,0.0014247741,0.002443904,0.0013474553,0.00022424739,0.0012832583,0.0010786827,0.001223384,0.0026317153],"category_scores_gemma":[0.021049213,0.0007243117,0.0051962878,0.0010232491,0.00050326844,0.0009244934,0.0007205025,0.0014777777,0.00010476693],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028508332,0.0010520922,0.0070535853,0.0007494062,0.0031348146,0.00015160823,0.000054566055,0.93927485,0.00059617247,0.0037790209,0.00057308533,0.015072532],"study_design_scores_gemma":[0.0055986242,0.0069949045,0.0061766617,0.00013028411,0.0029232728,0.00009713542,0.00009059207,0.97451186,0.0004779244,0.0023899893,0.0005530085,0.000055812474],"about_ca_topic_score_codex":0.011024374,"about_ca_topic_score_gemma":0.004620867,"teacher_disagreement_score":0.011024374,"about_ca_system_score_codex":0.004750522,"about_ca_system_score_gemma":0.0030623612,"threshold_uncertainty_score":0.053934872},"labels":[],"label_agreement":null},{"id":"W2328178778","doi":"10.1097/cad.0000000000000132","title":"Curcumin inhibits aerobic glycolysis and induces mitochondrial-mediated apoptosis through hexokinase II in human colorectal cancer cells in vitro","year":2014,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Government of Jiangsu Province","keywords":"Curcumin; Apoptosis; Mitochondrion; Glycolysis; Hexokinase; Cell biology; Cancer research; Protein kinase B; Intrinsic apoptosis; Anaerobic glycolysis; Chemistry; Cancer cell; Biology; Biochemistry; Programmed cell death; Metabolism; Cancer; Caspase; Genetics","score_opus":0.007410755609613626,"score_gpt":0.250974849820372,"score_spread":0.24356409421075836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328178778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98882127,0.0064565716,0.0017693589,0.00021368152,0.00007264825,0.00004307654,0.00063448644,0.00010380589,0.0018850503],"genre_scores_gemma":[0.9933329,0.0026411493,0.00076689763,0.00006287771,0.00001021368,0.00003776621,0.0008116528,0.000011098174,0.0023254643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992,0.000017468132,0.000010060793,0.000012112556,0.000015046728,0.000025316218],"domain_scores_gemma":[0.99995756,0.000008384925,0.000007943935,0.000007786112,0.000007409507,0.0000109282155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079346,0.00024642615,0.00022420955,0.00022035556,0.00012655396,0.00014749898,0.00008160683,0.000111994945,0.0013747809],"category_scores_gemma":[0.00008647268,0.00012788558,0.00019240555,0.00018684383,0.00009544285,0.000094841336,0.000116637944,0.0003613123,0.0002960748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091291196,0.0001479689,0.0005652577,0.00014896726,0.000025656704,0.00007567255,0.0000360757,0.00013970536,0.9942543,0.000053006555,0.00025252372,0.0033881033],"study_design_scores_gemma":[0.00012447327,0.0011246103,0.011925557,0.000011690256,0.000047549067,0.00020916582,0.000050811203,0.0008727091,0.98193043,0.000046833633,0.0036500343,0.000006205232],"about_ca_topic_score_codex":0.0029260209,"about_ca_topic_score_gemma":0.0050006495,"teacher_disagreement_score":0.0029260209,"about_ca_system_score_codex":0.00028485316,"about_ca_system_score_gemma":0.00023510131,"threshold_uncertainty_score":0.00581795},"labels":[],"label_agreement":null},{"id":"W2329169495","doi":"10.1097/00001813-200203000-00002","title":"The role of DNA repair in nitrogen mustard drug resistance","year":2002,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"RAD51; Nitrogen mustard; DNA repair; DNA damage; DNA; Homologous recombination; Cancer research; Biology; Homologous chromosome; Chemistry; Genetics; Gene; Chemotherapy","score_opus":0.011270867490387007,"score_gpt":0.27013716156457007,"score_spread":0.25886629407418305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329169495","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021060121,0.99787235,0.00020330226,0.0002430285,0.0001997739,0.0000034685531,0.000006994412,0.0000074167688,0.0012530985],"genre_scores_gemma":[0.001063596,0.9976157,0.00016729491,0.00013659995,0.00011734421,0.000004889794,0.0000125276765,0.0000012269978,0.00088080537],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998611,0.000024329313,0.000018877456,0.000026839845,0.000053920296,0.000014998893],"domain_scores_gemma":[0.99983406,0.000060828803,0.000025511972,0.0000069639705,0.000053356824,0.000019236393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041387754,0.0007379611,0.0010951875,0.0015372012,0.00032661727,0.0007535668,0.00084028905,0.0012546028,0.0019658455],"category_scores_gemma":[0.00044815004,0.0002261183,0.00026252226,0.0017387393,0.00052896974,0.0013642735,0.00046864935,0.0011252374,0.0018073219],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086893895,0.00006109494,0.00028228096,0.009792613,0.000049038852,0.00054530974,0.000092036644,0.00055267743,0.004482166,0.0046838527,0.023843247,0.95552874],"study_design_scores_gemma":[0.00002061836,0.0001000807,0.0013013285,0.0019488975,0.00005151615,0.0032143798,0.00008608822,0.00012156722,0.0013164327,0.0035872676,0.9882338,0.00001803979],"about_ca_topic_score_codex":0.0009867037,"about_ca_topic_score_gemma":0.0013040433,"teacher_disagreement_score":0.0019658455,"about_ca_system_score_codex":0.00075042015,"about_ca_system_score_gemma":0.00077760534,"threshold_uncertainty_score":0.006576419},"labels":[],"label_agreement":null},{"id":"W2330927692","doi":"10.1097/cad.0000000000000096","title":"LC-based targeted metabolomics analysis of nucleotides and identification of biomarkers associated with chemotherapeutic drugs in cultured cell models","year":2014,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Drug action; Drug; Nucleotide; Mechanism of action; Pharmacology; Computational biology; Metabolomics; Biology; Chemistry; Biochemistry; Cancer research; Bioinformatics; In vitro; Gene","score_opus":0.006977960851828034,"score_gpt":0.2304244932160295,"score_spread":0.22344653236420148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330927692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8023441,0.008231845,0.17946982,0.0002801791,0.00017774299,0.000596016,0.004220949,0.0007808461,0.003898434],"genre_scores_gemma":[0.81537545,0.009099769,0.16431004,0.0006709212,0.000083875144,0.0018377649,0.0044724112,0.00018501493,0.0039646877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99941754,0.00009143223,0.000050392555,0.00016649373,0.00022117414,0.000052978015],"domain_scores_gemma":[0.99969923,0.000081962964,0.000067346344,0.00003414291,0.00009920348,0.000018235412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000586955,0.00086920796,0.000753686,0.001362849,0.00035993988,0.0006152701,0.00025767775,0.00064314844,0.0006350106],"category_scores_gemma":[0.00076432875,0.00023077434,0.00062984653,0.0012993192,0.00036658274,0.00047955522,0.00043778177,0.0007202543,0.0002997326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012341376,0.00005184194,0.0016287531,0.00012975567,0.00003719545,0.00007059021,0.000043313954,0.0005215304,0.9892489,0.00012740298,0.00007691503,0.007940388],"study_design_scores_gemma":[0.000010461839,0.00035478137,0.015000229,0.000016640348,0.00012942083,0.00018256468,0.00008130492,0.009142151,0.97258985,0.00027771154,0.0021736713,0.00004127357],"about_ca_topic_score_codex":0.0018350527,"about_ca_topic_score_gemma":0.002823017,"teacher_disagreement_score":0.0018350527,"about_ca_system_score_codex":0.0004074898,"about_ca_system_score_gemma":0.0005982698,"threshold_uncertainty_score":0.003648758},"labels":[],"label_agreement":null},{"id":"W2332257070","doi":"10.1097/00001813-200303000-00002","title":"Interaction of 5-aza-2′-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3σ, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells","year":2003,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Depsipeptide; Cancer research; Carcinogenesis; DNA methylation; Histone deacetylase inhibitor; Breast carcinoma; Molecular biology; Chemistry; Epigenetics; Biology; Cancer; Histone deacetylase; Breast cancer; DNA; Histone; Gene expression; Gene; Biochemistry; Genetics","score_opus":0.008826567789554068,"score_gpt":0.26565926964723463,"score_spread":0.2568327018576806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332257070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922281,0.0052667484,0.00055416627,0.000058696744,0.00005560705,0.000027265693,0.00028473997,0.000022267599,0.0015024855],"genre_scores_gemma":[0.9946956,0.002078849,0.0010214811,0.000054389224,0.000024993227,0.0000362766,0.0005155736,0.0000069217017,0.0015658541],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998393,0.000040921,0.000013882363,0.000029619438,0.00004165422,0.000034693483],"domain_scores_gemma":[0.9999044,0.000032229087,0.000018633687,0.000009429847,0.000011167376,0.000024098976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015256512,0.00029432733,0.00039843388,0.00014201389,0.0000857899,0.0001347262,0.00016644188,0.00018331395,0.0011574494],"category_scores_gemma":[0.00011611328,0.00013589916,0.00019354653,0.00012304455,0.00009955044,0.000075167234,0.000090513226,0.00032005223,0.00023744277],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003103613,0.000054630254,0.00015919954,0.00006302685,0.000013518288,0.000039667717,0.00000986201,0.000080384176,0.9976707,0.000029794499,0.000040786243,0.0015279789],"study_design_scores_gemma":[0.00003083659,0.0013259017,0.0036344265,0.0000049381706,0.000024612875,0.00016347332,0.000011747336,0.0005136218,0.9925425,0.000007023792,0.0017378966,0.0000029789403],"about_ca_topic_score_codex":0.00072544627,"about_ca_topic_score_gemma":0.001560465,"teacher_disagreement_score":0.0011574494,"about_ca_system_score_codex":0.00018106936,"about_ca_system_score_gemma":0.0001916342,"threshold_uncertainty_score":0.0038720965},"labels":[],"label_agreement":null},{"id":"W2333316232","doi":"10.1097/cad.0b013e32834ea5b3","title":"Sorafenib in combination with ionizing radiation has a greater anti-tumour activity in a breast cancer model","year":2012,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research; McGill University","keywords":"Sorafenib; Clonogenic assay; Cancer research; Medicine; Annexin; Vascular endothelial growth factor; MAPK/ERK pathway; Apoptosis; Radiation therapy; In vivo; Cancer; Internal medicine; Pharmacology; Oncology; Hepatocellular carcinoma; Kinase; Biology; Immunology; VEGF receptors; Flow cytometry","score_opus":0.020607606022109204,"score_gpt":0.2677900791661434,"score_spread":0.2471824731440342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333316232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911213,0.0029315776,0.0025187193,0.0002332012,0.00015451438,0.00009784202,0.0006461325,0.00012411212,0.0021725984],"genre_scores_gemma":[0.9843667,0.0028422198,0.0037021062,0.00008942166,0.00003485131,0.00017148773,0.0011783106,0.00002988283,0.0075850007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99973756,0.000053196105,0.000021316717,0.000051801922,0.00007109667,0.00006500032],"domain_scores_gemma":[0.9999205,0.000011744845,0.000015633525,0.00001266597,0.000009761179,0.00002973843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024936895,0.0005076494,0.00072539895,0.0004327709,0.00018323533,0.00026797113,0.00028690687,0.00033527854,0.0020231563],"category_scores_gemma":[0.00008536644,0.00021401707,0.0005092553,0.00035889912,0.00017488936,0.00024078104,0.00016297493,0.0009700634,0.00045310732],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015052905,0.0008436127,0.00015566738,0.00013397259,0.000026629365,0.00007224743,0.00005529965,0.00034261067,0.9927281,0.00009666105,0.000264029,0.0037757868],"study_design_scores_gemma":[0.00018966169,0.007925043,0.0023470046,0.0000081919825,0.0000702897,0.00035948175,0.00004603069,0.0019266158,0.98199296,0.000051720293,0.0050687925,0.000014327582],"about_ca_topic_score_codex":0.0014607481,"about_ca_topic_score_gemma":0.0022277199,"teacher_disagreement_score":0.0020231563,"about_ca_system_score_codex":0.00029183767,"about_ca_system_score_gemma":0.00040638054,"threshold_uncertainty_score":0.006768167},"labels":[],"label_agreement":null},{"id":"W2333517888","doi":"10.1097/00001813-200301000-00004","title":"In vitro studies on the lymphoma growth-inhibitory activity of sulfasalazine","year":2003,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Synthesis and Biological Evaluation","field":"Chemistry","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Sulfasalazine; In vitro; Inhibitory postsynaptic potential; Lymphoma; Cancer research; Pharmacology; Chemistry; Medicine; Immunology; Internal medicine; Biochemistry","score_opus":0.047018581842425994,"score_gpt":0.3052550081109162,"score_spread":0.2582364262684902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333517888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714797,0.016441887,0.006312399,0.00012662413,0.000105746665,0.000115662384,0.0012729691,0.00015231382,0.003992627],"genre_scores_gemma":[0.9812097,0.0077245045,0.0051836134,0.0000528673,0.000060170343,0.00011985809,0.002160801,0.00004504041,0.0034436076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996772,0.000112235815,0.000025552501,0.000048245332,0.00007687791,0.000059988193],"domain_scores_gemma":[0.9997023,0.00013784118,0.00004309435,0.00003627241,0.000045228182,0.000035173125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003906903,0.00070981245,0.0005509492,0.00024864863,0.00019932087,0.0002818983,0.00045537236,0.0002650263,0.0015139169],"category_scores_gemma":[0.00019927011,0.00018697428,0.0004967047,0.00032424353,0.00020638312,0.00016600761,0.00020116004,0.0005954014,0.000623233],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002428256,0.000082093306,0.00011262024,0.0000730842,0.000010468354,0.00004661709,0.000035169098,0.00012036856,0.99800676,0.000050776107,0.000042099527,0.0011771194],"study_design_scores_gemma":[0.000019467318,0.0012186939,0.0010070173,0.0000050792346,0.000023595589,0.000091207774,0.000013048591,0.00043868585,0.9958247,0.000009828097,0.0013460258,0.0000026666346],"about_ca_topic_score_codex":0.0029781517,"about_ca_topic_score_gemma":0.0034489415,"teacher_disagreement_score":0.0029781517,"about_ca_system_score_codex":0.00040558135,"about_ca_system_score_gemma":0.0002901794,"threshold_uncertainty_score":0.0059216022},"labels":[],"label_agreement":null},{"id":"W2333659151","doi":"10.1097/cad.0b013e328334992c","title":"Tranilast inhibits cell proliferation and migration and promotes apoptosis in murine breast cancer","year":2010,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Tranilast; Cancer research; Cell growth; Apoptosis; Cyclin D1; Cell cycle; Chemistry; Cyclin D; Medicine; Pharmacology; Biochemistry","score_opus":0.004213468023178503,"score_gpt":0.23211042846733235,"score_spread":0.22789696044415383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333659151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302,0.002740012,0.0006782041,0.00013552845,0.000042830718,0.0000576876,0.00045972987,0.000148651,0.0027173646],"genre_scores_gemma":[0.9871377,0.004431927,0.0015176926,0.0001081523,0.000023107226,0.00008083365,0.0009887994,0.000031007054,0.005680787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999866,0.000026940348,0.000011333049,0.000015960897,0.000035427518,0.00004440518],"domain_scores_gemma":[0.9999043,0.000014757069,0.000028415252,0.000014229179,0.000010610281,0.00002775876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001255053,0.00053917686,0.00033321045,0.00056789594,0.00018430383,0.00017359627,0.00022588386,0.0002737945,0.0019625383],"category_scores_gemma":[0.00009910669,0.00018796671,0.00031027518,0.00023322723,0.00014981754,0.0001682151,0.000118370845,0.00057564006,0.00048793707],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043536627,0.00023642502,0.00021299925,0.000046122692,0.000009004513,0.000058071924,0.000020927257,0.0001158439,0.99519545,0.000048807397,0.000080763406,0.0035401613],"study_design_scores_gemma":[0.000086547254,0.0037722068,0.0054411753,0.000010521805,0.000026602947,0.00022722776,0.000025339672,0.0008865328,0.98734564,0.000047292324,0.0021247126,0.000006198199],"about_ca_topic_score_codex":0.0012205039,"about_ca_topic_score_gemma":0.0023427634,"teacher_disagreement_score":0.0019625383,"about_ca_system_score_codex":0.00026294234,"about_ca_system_score_gemma":0.00019699184,"threshold_uncertainty_score":0.0065653324},"labels":[],"label_agreement":null},{"id":"W2346252846","doi":"10.1097/cad.0000000000000366","title":"Pharmacokinetics of cabozantinib tablet and capsule formulations in healthy adults","year":2016,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Caprion (Canada); Celerion (Canada)","funders":"","keywords":"Bioequivalence; Cabozantinib; Cmax; Pharmacokinetics; Medicine; Dosing; Capsule; Confidence interval; Pharmacology; Medullary thyroid cancer; Urology; Cancer; Internal medicine; Thyroid cancer","score_opus":0.015577115231370895,"score_gpt":0.31329053114583844,"score_spread":0.29771341591446754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346252846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99624324,0.0015441839,0.0005106636,0.00005344744,0.000012962955,0.00012637027,0.0005152434,0.000031375992,0.0009626078],"genre_scores_gemma":[0.99743646,0.00040855943,0.000535605,0.00019809735,0.000019070385,0.00011085886,0.000578051,0.00000667538,0.0007066986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970835,0.00007889675,0.000023021612,0.00009842147,0.00006368752,0.000027650922],"domain_scores_gemma":[0.9997484,0.00006891401,0.000062518746,0.00002087655,0.000039646737,0.000059482874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053818926,0.00026338844,0.00056502497,0.00015650409,0.0001963844,0.00029351076,0.000086567314,0.0004659074,0.0008213389],"category_scores_gemma":[0.0011434556,0.00017750666,0.00023404654,0.00019088505,0.00019445347,0.00028112184,0.00010616836,0.00039056534,0.00031549044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19258778,0.0070875734,0.4062577,0.00072775315,0.0018382312,0.0014446024,0.0027160274,0.0018826295,0.19249421,0.0005038367,0.005432694,0.1870269],"study_design_scores_gemma":[0.0036223326,0.07823953,0.9032606,0.000018965697,0.00048369143,0.001400101,0.0003064837,0.00216955,0.0066947495,0.00014240615,0.0036180206,0.000043568572],"about_ca_topic_score_codex":0.0020599,"about_ca_topic_score_gemma":0.0015655027,"teacher_disagreement_score":0.0020599,"about_ca_system_score_codex":0.00021669338,"about_ca_system_score_gemma":0.00023414342,"threshold_uncertainty_score":0.004095793},"labels":[],"label_agreement":null},{"id":"W2407413189","doi":"10.1097/00001813-200211002-00006","title":"Stem-cell transplantation in non-Hodgkinʼs lymphoma: improving outcome","year":2002,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Autologous stem-cell transplantation; Medicine; Rituximab; Transplantation; Oncology; Stem cell; Minimal residual disease; Lymphoma; Follicular lymphoma; Internal medicine; Mantle cell lymphoma; Non-Hodgkin's lymphoma; Immunology; Leukemia; Biology","score_opus":0.04044046465829004,"score_gpt":0.3316298935328376,"score_spread":0.2911894288745476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407413189","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89427936,0.09698172,0.0020655717,0.001212254,0.0004669673,0.0001256691,0.00015789099,0.0001463959,0.004564183],"genre_scores_gemma":[0.97820365,0.017971037,0.0010172435,0.0006128439,0.00060638046,0.00005526407,0.00044438228,0.000011389549,0.001077836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999941,0.0000193085,0.000005978842,0.000007020726,0.000011853269,0.000014956039],"domain_scores_gemma":[0.999907,0.000016426706,0.000014217742,0.0000071256877,0.000009145508,0.000046007313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033237698,0.00015804346,0.000311564,0.0002523953,0.00011196366,0.00022469084,0.00013638534,0.00023296654,0.00097352144],"category_scores_gemma":[0.00025080174,0.000021107971,0.00021943996,0.00025884117,0.00014642207,0.00016386781,0.00018481346,0.0003668199,0.00019203332],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005195563,0.002080976,0.027098622,0.00072491023,0.0001844966,0.0015935575,0.00016212817,0.0005975994,0.011386416,0.000680512,0.003940329,0.94635487],"study_design_scores_gemma":[0.0056852046,0.087769665,0.7509497,0.0015104181,0.0017624719,0.02812384,0.00049403164,0.0048900438,0.025852853,0.0061554285,0.08673601,0.00007032841],"about_ca_topic_score_codex":0.00017106434,"about_ca_topic_score_gemma":0.0002535049,"teacher_disagreement_score":0.00097352144,"about_ca_system_score_codex":0.00016663308,"about_ca_system_score_gemma":0.00014517074,"threshold_uncertainty_score":0.0032567382},"labels":[],"label_agreement":null},{"id":"W2567819266","doi":"10.1097/cad.0000000000000469","title":"Effect of dihydroartemisinin on UHRF1 gene expression in human prostate cancer PC-3 cells","year":2017,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artron Bioresearch (Canada)","funders":"Chongqing Municipal Education Commission","keywords":"DNMT1; Downregulation and upregulation; DNA methylation; Apoptosis; Cancer research; Cell cycle; Prostate cancer; Biology; Cancer cell; DNA methyltransferase; Methylation; Cancer; Molecular biology; Chemistry; Gene expression; Biochemistry; Gene; Genetics","score_opus":0.009098106776582633,"score_gpt":0.31571888425991645,"score_spread":0.30662077748333383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567819266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815176,0.011030357,0.002763758,0.00023678686,0.00007917037,0.000063704734,0.0016452215,0.00015263402,0.002510773],"genre_scores_gemma":[0.98671603,0.00461145,0.0034020827,0.00013575096,0.000018538143,0.00007961922,0.0018653444,0.000019510022,0.0031516782],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989355,0.00001807289,0.000011481946,0.000028067248,0.000028960381,0.000019913956],"domain_scores_gemma":[0.9999491,0.00001259495,0.000009075939,0.000008402232,0.000011191353,0.000009614584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000939227,0.0002551054,0.00035616112,0.00021224852,0.00018831527,0.00016393985,0.00015483865,0.00019024363,0.0010310591],"category_scores_gemma":[0.000091128815,0.000107580956,0.00035481094,0.00026883403,0.00014065718,0.00014288374,0.000098798235,0.00049760035,0.00024600053],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019345296,0.00003710738,0.00018690366,0.00007307501,0.000011004787,0.000032326057,0.000025806472,0.00007270832,0.99739885,0.000047380745,0.00006933372,0.0018520254],"study_design_scores_gemma":[0.000017632097,0.00047400582,0.0036436713,0.0000037864793,0.000027353126,0.00009390562,0.000030270798,0.00047926523,0.9927289,0.000028215727,0.0024681166,0.0000047874623],"about_ca_topic_score_codex":0.0021130473,"about_ca_topic_score_gemma":0.0032455006,"teacher_disagreement_score":0.0021130473,"about_ca_system_score_codex":0.00026625872,"about_ca_system_score_gemma":0.00024831033,"threshold_uncertainty_score":0.004201472},"labels":[],"label_agreement":null},{"id":"W2592985951","doi":"10.1097/cad.0000000000000493","title":"A systematic review and pooled analysis of retrospective series of eribulin in metastatic breast cancer","year":2017,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sault Area Hospital","funders":"","keywords":"Medicine; Eribulin; Capecitabine; Internal medicine; Breast cancer; Metastatic breast cancer; Oncology; Clinical trial; Confidence interval; Retrospective cohort study; Cancer; Surgery","score_opus":0.04661719267652718,"score_gpt":0.4187347429406821,"score_spread":0.3721175502641549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592985951","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012021656,0.9809265,0.0008985426,0.00018646158,0.00015699423,0.0010533583,0.0041502053,0.0000224828,0.00058377435],"genre_scores_gemma":[0.17817971,0.80984277,0.003076253,0.000909369,0.00022834002,0.003059795,0.004352117,0.000040979772,0.00031069617],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96637017,0.011392248,0.015605713,0.0025757742,0.0036458303,0.00041019992],"domain_scores_gemma":[0.934274,0.038212698,0.017163068,0.0027596864,0.0071052765,0.00048525893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020540807,0.0017114615,0.011196683,0.016059877,0.0006030164,0.002689305,0.0016698939,0.0012240116,0.0023130774],"category_scores_gemma":[0.0669924,0.0012464107,0.013032015,0.01910822,0.0009841796,0.0016994827,0.0015382869,0.0007844917,0.000377411],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010086026,0.00003152206,0.016118322,0.79236495,0.16143373,0.0003448274,0.00027641773,0.00026272304,0.00034413324,0.0001979591,0.0019501757,0.02566666],"study_design_scores_gemma":[0.00075544935,0.00050414784,0.043397833,0.2421614,0.6959547,0.0010248267,0.0003981392,0.00019701464,0.0004901494,0.00037976512,0.014639835,0.000096772565],"about_ca_topic_score_codex":0.006022828,"about_ca_topic_score_gemma":0.018178562,"teacher_disagreement_score":0.020540807,"about_ca_system_score_codex":0.0027071175,"about_ca_system_score_gemma":0.007054083,"threshold_uncertainty_score":0.10863143},"labels":[],"label_agreement":null},{"id":"W2794034349","doi":"10.1097/cad.0000000000000589","title":"Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer","year":2018,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Pfizer","keywords":"Palbociclib; Letrozole; Medicine; QT interval; Placebo; Breast cancer; Dosing; Internal medicine; Anesthesia; Cardiology; Metastatic breast cancer; Cancer; Aromatase","score_opus":0.011148312293442708,"score_gpt":0.2969571145477851,"score_spread":0.2858088022543424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794034349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91509616,0.07774111,0.00053291244,0.0010734044,0.00019851026,0.00027998304,0.00035409344,0.000053647957,0.004670209],"genre_scores_gemma":[0.98962057,0.008052561,0.00033152636,0.0009413267,0.00025489405,0.00009072299,0.00025343633,0.0000076206456,0.00044736065],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99950635,0.00027494613,0.000038094244,0.000051050556,0.000094820774,0.000034698904],"domain_scores_gemma":[0.9990715,0.00043756803,0.0002754933,0.000045687975,0.00006444531,0.00010538849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011026196,0.00027026085,0.0011807042,0.00015553873,0.00015915287,0.00037874404,0.00026904684,0.000461365,0.0015041399],"category_scores_gemma":[0.0021614465,0.00014136054,0.00042329342,0.00030441413,0.00021190535,0.00027524316,0.00015103718,0.0009198135,0.0002775389],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30455944,0.0033236241,0.109661356,0.0033485866,0.002618938,0.0012121833,0.000245203,0.0018847624,0.07748875,0.00047192452,0.005082694,0.49010262],"study_design_scores_gemma":[0.11982125,0.21419059,0.6056462,0.0005037681,0.0053310785,0.0043980833,0.00024534328,0.0031957275,0.014015151,0.0011515508,0.031435434,0.0000657585],"about_ca_topic_score_codex":0.0005980437,"about_ca_topic_score_gemma":0.0015117396,"teacher_disagreement_score":0.0015041399,"about_ca_system_score_codex":0.000425241,"about_ca_system_score_gemma":0.00043085104,"threshold_uncertainty_score":0.005831301},"labels":[],"label_agreement":null},{"id":"W2805530155","doi":"10.1097/cad.0000000000000661","title":"A case of severe Pembrolizumab-induced neutropenia","year":2018,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Pembrolizumab; Medicine; Neutropenia; Immunosuppression; Adverse effect; Internal medicine; Immunology; Gastroenterology; Cancer; Chemotherapy; Immunotherapy","score_opus":0.02603540285744438,"score_gpt":0.3146937041468664,"score_spread":0.28865830128942205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805530155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9112974,0.014366734,0.010769934,0.016044308,0.0016626229,0.00078694336,0.0008416402,0.00049585913,0.043734528],"genre_scores_gemma":[0.9894629,0.0018164257,0.002393777,0.003192604,0.000977708,0.000056837674,0.000134556,0.000031290623,0.0019339652],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99892944,0.00013878867,0.00011051045,0.00020889958,0.0001452951,0.00046707314],"domain_scores_gemma":[0.9982222,0.00045138807,0.00030647864,0.00017684484,0.000119006996,0.00072400906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051240413,0.0022355854,0.001229917,0.002763356,0.0030452178,0.0019027268,0.0014053817,0.0066183107,0.00217678],"category_scores_gemma":[0.0030658324,0.0013216088,0.0014643352,0.0017645714,0.0013741624,0.0017533738,0.0016688044,0.0057046846,0.00078736426],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035410158,0.00004337463,0.002105725,0.0000240771,0.000007305919,0.995327,0.00008718091,0.00008957587,0.00036882397,0.00023510399,0.00035873035,0.0013176253],"study_design_scores_gemma":[0.000014518809,0.00005324939,0.0017272279,0.000018933115,0.000006947981,0.9968394,0.000047867474,0.00025300143,0.00020534826,0.00019430915,0.00063185574,0.0000073395245],"about_ca_topic_score_codex":0.003983539,"about_ca_topic_score_gemma":0.0062189107,"teacher_disagreement_score":0.0066183107,"about_ca_system_score_codex":0.0025942186,"about_ca_system_score_gemma":0.0013621431,"threshold_uncertainty_score":0.018822432},"labels":[],"label_agreement":null},{"id":"W2936620117","doi":"10.1097/cad.0000000000000685","title":"Cannabis-related cognitive impairment","year":2018,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cannabis; Neurocognitive; Medicine; Psychiatry; Cognition; Anxiety; Effects of cannabis; Depression (economics); Effects of sleep deprivation on cognitive performance; Clinical psychology","score_opus":0.013207524565457915,"score_gpt":0.3263477358163184,"score_spread":0.31314021125086045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936620117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958943,0.0013941517,0.00004546479,0.0000689591,0.000009564673,0.000037037593,0.00020428906,0.000005092118,0.0023410055],"genre_scores_gemma":[0.9991529,0.00030834062,0.000032044056,0.00003550334,0.00001024503,0.000006632281,0.000116048745,6.6528145e-7,0.00033764882],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998248,0.000020585652,0.000019912435,0.000035013436,0.00004985661,0.000049877155],"domain_scores_gemma":[0.9993222,0.00009238516,0.00032486257,0.00002576182,0.00009775739,0.00013700232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023879658,0.0003179986,0.00040637763,0.0006230209,0.0008655718,0.00037827512,0.00021973245,0.00020873577,0.0029879867],"category_scores_gemma":[0.0012392275,0.00008214054,0.0002964027,0.00050945627,0.00029273692,0.00018695966,0.00036616361,0.00041165613,0.00021609051],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006504506,0.0003016174,0.98259026,0.00013086261,0.00016187198,0.0018007986,0.00018440087,0.00009128105,0.0010510138,0.000055102224,0.00025367216,0.012728606],"study_design_scores_gemma":[0.000012801439,0.00031925496,0.9959628,0.000014946998,0.000042976986,0.0030672923,0.00007705837,0.000049472997,0.00014009325,0.00004135268,0.0002682414,0.0000037161908],"about_ca_topic_score_codex":0.00626304,"about_ca_topic_score_gemma":0.006836094,"teacher_disagreement_score":0.00626304,"about_ca_system_score_codex":0.0004923222,"about_ca_system_score_gemma":0.00059279415,"threshold_uncertainty_score":0.012453198},"labels":[],"label_agreement":null},{"id":"W2978014264","doi":"10.1097/cad.0000000000000653","title":"DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy","year":2018,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Occupational Cancer Research Centre","funders":"","keywords":"Docetaxel; Taxane; Paclitaxel; Medicine; Triple-negative breast cancer; Immunotherapy; Breast cancer; Pharmacology; Metastatic breast cancer; Chemotherapy; Cancer; Cancer research; Oncology; Internal medicine","score_opus":0.03358925432978724,"score_gpt":0.33690315042350005,"score_spread":0.30331389609371284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978014264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98580825,0.0042327973,0.001947759,0.0003892311,0.000084042375,0.00018610209,0.0011874214,0.00018007195,0.0059845024],"genre_scores_gemma":[0.9878286,0.0027654602,0.0024091403,0.000109947236,0.00004271413,0.00013395329,0.0020649817,0.000038534276,0.0046066437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989295,0.000023298797,0.0000065908325,0.00001531719,0.000033808374,0.000028000662],"domain_scores_gemma":[0.999908,0.000011897906,0.000018727033,0.000009117726,0.00001406355,0.000038266808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015370932,0.00058074086,0.0006216659,0.00043634957,0.00017035936,0.000298491,0.00036821404,0.0002878705,0.0048579476],"category_scores_gemma":[0.00016346129,0.00016928368,0.00034751324,0.00024382517,0.00017783737,0.00029193258,0.00017827164,0.0008077418,0.00064221065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003264395,0.0012831171,0.00068240525,0.00030633312,0.00006236219,0.0001588876,0.00003334511,0.0013914098,0.959074,0.00036566914,0.0009813955,0.03239677],"study_design_scores_gemma":[0.0012551765,0.030292438,0.010959116,0.000031802596,0.00018142747,0.0015884412,0.000048330923,0.003311712,0.92997336,0.0002474379,0.022077644,0.000033069307],"about_ca_topic_score_codex":0.000937082,"about_ca_topic_score_gemma":0.0018542326,"teacher_disagreement_score":0.0048579476,"about_ca_system_score_codex":0.0003913786,"about_ca_system_score_gemma":0.0005274485,"threshold_uncertainty_score":0.016251504},"labels":[],"label_agreement":null},{"id":"W3048587704","doi":"10.1097/cad.0000000000000962","title":"A novel screening approach comparing kinase activity of small molecule inhibitors with similar molecular structures and distinct biologic effects in triple-negative breast cancer to identify targetable signaling pathways","year":2020,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences","keywords":"Triple-negative breast cancer; Cancer research; Breast cancer; Kinase; Metastasis; Cancer; Epithelial–mesenchymal transition; Phenotype; Biology; Cancer cell; Signal transduction; Medicine; Internal medicine; Cell biology; Gene; Genetics","score_opus":0.03351299110919341,"score_gpt":0.2767625854133924,"score_spread":0.24324959430419896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048587704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649656,0.005572265,0.01905426,0.00025694867,0.00010286668,0.00094233424,0.0026819028,0.0003546439,0.0060691987],"genre_scores_gemma":[0.9581395,0.00490989,0.026388383,0.0002610595,0.00002442259,0.0006575202,0.0032882122,0.00004168925,0.0062892577],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974364,0.00003419791,0.000026491549,0.000059955237,0.000091390306,0.00004429731],"domain_scores_gemma":[0.9998903,0.000020386158,0.000021903797,0.000014816103,0.000030127003,0.000022334661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033859687,0.0007350946,0.0006703464,0.00084818096,0.000267908,0.0004588497,0.00034547152,0.00031597086,0.002088313],"category_scores_gemma":[0.00021637544,0.00022306303,0.00051888207,0.0005535466,0.00019692046,0.00033027862,0.00024606037,0.00068367174,0.0003822784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023741076,0.0003030634,0.00034461165,0.00014432342,0.00003117631,0.00005919746,0.000020874073,0.000408798,0.9890603,0.00015860081,0.00014678559,0.009084881],"study_design_scores_gemma":[0.00018978684,0.0053337403,0.0043998784,0.000015392134,0.00012934736,0.00041012216,0.000034800425,0.0019427127,0.9833673,0.00007992187,0.0040717786,0.000025265603],"about_ca_topic_score_codex":0.00097602577,"about_ca_topic_score_gemma":0.003859169,"teacher_disagreement_score":0.002088313,"about_ca_system_score_codex":0.0004877202,"about_ca_system_score_gemma":0.0006556329,"threshold_uncertainty_score":0.0069860816},"labels":[],"label_agreement":null},{"id":"W3082347199","doi":"10.1097/cad.0000000000000951","title":"The positive correlation between drug addiction and drug dosage in vemurafenib-resistant melanoma cells is underpinned by activation of ERK1/2-FRA-1 pathway","year":2020,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Vemurafenib; Melanoma; Cancer research; Downregulation and upregulation; Medicine; Drug resistance; Pharmacology; clone (Java method); Drug; Addiction; Biology; Metastatic melanoma; Psychiatry; Genetics; Gene","score_opus":0.006785868286619531,"score_gpt":0.21391821300337346,"score_spread":0.20713234471675393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082347199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995227,0.0014828404,0.0014659709,0.00008560683,0.000020445192,0.000028522481,0.000566799,0.00005072332,0.0010721222],"genre_scores_gemma":[0.9947352,0.0006697271,0.0013390047,0.000048171558,0.000008243264,0.00006472185,0.0007356776,0.000008971109,0.0023902105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99968386,0.000051758943,0.000046949055,0.00006718853,0.00010188534,0.00004834712],"domain_scores_gemma":[0.9996107,0.00007820574,0.00012499923,0.000046095953,0.00007483967,0.00006514659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001290908,0.00026162897,0.00032421973,0.00034667243,0.000117929434,0.00025976804,0.00013452696,0.00025473133,0.0015081039],"category_scores_gemma":[0.00026954725,0.00020866234,0.00024415832,0.00033830066,0.0001459519,0.00025738677,0.00018694202,0.0005966915,0.0002862285],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023385062,0.00008240955,0.0029120822,0.000047019355,0.000014263563,0.000068616035,0.00003767594,0.00007543166,0.9943838,0.00003725086,0.000058273337,0.0020493043],"study_design_scores_gemma":[0.000021539343,0.0013595179,0.12060513,0.000010166221,0.000030661,0.0006716493,0.0001730366,0.001970408,0.8726041,0.0000898341,0.0024405052,0.000023544435],"about_ca_topic_score_codex":0.0005781334,"about_ca_topic_score_gemma":0.00072948146,"teacher_disagreement_score":0.0015081039,"about_ca_system_score_codex":0.00015339526,"about_ca_system_score_gemma":0.00011303285,"threshold_uncertainty_score":0.0050451756},"labels":[],"label_agreement":null},{"id":"W4318967494","doi":"10.1097/cad.0000000000001429","title":"Efficacy of Duloxetine on electrodiagnostic findings of Paclitaxel-induced peripheral neuropathy, does it have a prophylactic effect? A randomized clinical trial","year":2022,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; Island Health","funders":"","keywords":"Duloxetine; Peripheral neuropathy; Medicine; Chemotherapy-induced peripheral neuropathy; Paclitaxel; Randomized controlled trial; Peripheral; Clinical trial; Internal medicine; Chemotherapy; Alternative medicine; Diabetes mellitus; Pathology","score_opus":0.027619715702373142,"score_gpt":0.3820460627967212,"score_spread":0.35442634709434806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318967494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978403,0.011843717,0.00068827125,0.0010062738,0.0009647602,0.004591979,0.0004973867,0.00009062875,0.0019138466],"genre_scores_gemma":[0.9852657,0.0059807007,0.0013932559,0.0011212811,0.00094473653,0.0036803326,0.000406054,0.000011980037,0.0011960682],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99864906,0.00094226253,0.00012556255,0.00011695392,0.000073247735,0.000092889924],"domain_scores_gemma":[0.9984199,0.000845332,0.00028439835,0.00012156092,0.00009104735,0.00023778195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022012042,0.00088012055,0.0028853102,0.00042621416,0.0004035621,0.0005610879,0.0006750125,0.0023785797,0.0046080058],"category_scores_gemma":[0.002955675,0.00047020544,0.0015229689,0.0003447439,0.00093361444,0.00055989367,0.00023475612,0.0013511311,0.0004734331],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97363764,0.005946632,0.0003276623,0.00085350533,0.0007106365,0.000037123464,0.000021036094,0.00009709364,0.0016656583,0.000076025935,0.00020457919,0.016422356],"study_design_scores_gemma":[0.91288424,0.08490429,0.0009360974,0.00004640703,0.0004955487,0.000018597373,0.000008742588,0.00016294573,0.00023395073,0.000050684495,0.00025119676,0.0000072114826],"about_ca_topic_score_codex":0.00060615456,"about_ca_topic_score_gemma":0.0013652659,"teacher_disagreement_score":0.0046080058,"about_ca_system_score_codex":0.00045932934,"about_ca_system_score_gemma":0.0007381084,"threshold_uncertainty_score":0.015415311},"labels":[],"label_agreement":null},{"id":"W4390533628","doi":"10.1097/cad.0000000000001565","title":"Tumor neoantigens derived from RNA editing events show significant clinical relevance in melanoma patients treated with immunotherapy","year":2023,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"Immunotherapy; Clinical significance; Melanoma; Medicine; Epitope; Antigen; Major histocompatibility complex; Immunology; Internal medicine; Oncology; Cancer research; Cancer","score_opus":0.014069221652476555,"score_gpt":0.28332261763742095,"score_spread":0.2692533959849444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390533628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962907,0.002371674,0.00027158903,0.00008651217,0.000019941777,0.000013785104,0.00013830884,0.000013143041,0.0007944249],"genre_scores_gemma":[0.9990004,0.00035331168,0.00017400023,0.00006559943,0.000026735075,0.0000095530895,0.00015078095,0.000004598956,0.00021519647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997019,0.000084445375,0.000029782672,0.00007747717,0.00005349543,0.000052818115],"domain_scores_gemma":[0.9991524,0.00023708837,0.00040680086,0.00003965955,0.00006962844,0.000094451796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039620636,0.00014701525,0.00038112764,0.00026896707,0.000242237,0.00047302913,0.00012163476,0.00030456655,0.001054995],"category_scores_gemma":[0.0012678094,0.00011478485,0.00035058748,0.0003586578,0.00013903924,0.00028218684,0.0002129444,0.0005654333,0.0001757466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018293015,0.00011492027,0.9531935,0.00010066076,0.00016662142,0.00055207836,0.00013047806,0.0003363041,0.0090462,0.0000569936,0.0003480729,0.03412482],"study_design_scores_gemma":[0.00004368399,0.0008554619,0.9911432,0.00003413279,0.00025869237,0.002438728,0.00019380244,0.00096198777,0.0018690923,0.00018092788,0.0020092635,0.000011075589],"about_ca_topic_score_codex":0.00024730054,"about_ca_topic_score_gemma":0.00048058893,"teacher_disagreement_score":0.001054995,"about_ca_system_score_codex":0.00019134261,"about_ca_system_score_gemma":0.00015378308,"threshold_uncertainty_score":0.0035293102},"labels":[],"label_agreement":null},{"id":"W4399850500","doi":"10.1097/cad.0000000000001627","title":"Transcriptional regulation of CYR61 and CTGF by LM98: a synthetic YAP-TEAD inhibitor that targets in-vitro vasculogenic mimicry in glioblastoma cells","year":2024,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Fonds de recherche du Québec – Nature et technologies; Natural Sciences and Engineering Research Council of Canada; Réseau Québécois de Recherche sur les Médicaments; Université du Québec à Montréal","keywords":"Vasculogenic mimicry; CTGF; CYR61; Hippo signaling pathway; Biology; Cancer research; Gene silencing; Angiogenesis; Small interfering RNA; Cell biology; Signal transduction; Cancer; Cell culture; Metastasis; Gene; Genetics; Transfection; Growth factor","score_opus":0.005938760881203694,"score_gpt":0.22194700000456552,"score_spread":0.21600823912336184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399850500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940977,0.0010199207,0.002231674,0.000106824344,0.000027282284,0.00003720684,0.00086701807,0.00012254926,0.0014898158],"genre_scores_gemma":[0.99261415,0.0005940481,0.002731449,0.000048149406,0.000008670759,0.000067384964,0.0015839923,0.000025315867,0.002326765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987304,0.000019649158,0.0000127859275,0.000027311446,0.000037477035,0.000029801351],"domain_scores_gemma":[0.999956,0.000008176176,0.000014146538,0.0000064694664,0.0000053818267,0.0000098489945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012253126,0.00024216264,0.00025391296,0.00016610925,0.00012244003,0.00022478578,0.00015877695,0.00015129577,0.0008835122],"category_scores_gemma":[0.00008037537,0.00009597036,0.00019466663,0.00014569715,0.00016386108,0.00009096967,0.00013016754,0.0003303637,0.00027987402],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099936224,0.00002957032,0.00009848524,0.000019443765,0.0000019355448,0.000015501078,0.000007894136,0.00006866545,0.9989222,0.000029582872,0.000044475524,0.00066231727],"study_design_scores_gemma":[0.000010787255,0.00015032204,0.001211162,0.000001664945,0.00000504207,0.000036471796,0.000008393338,0.0007592533,0.9967961,0.000006934691,0.0010123193,0.0000015019064],"about_ca_topic_score_codex":0.0009838556,"about_ca_topic_score_gemma":0.0014506433,"teacher_disagreement_score":0.0009838556,"about_ca_system_score_codex":0.00033236528,"about_ca_system_score_gemma":0.00021530467,"threshold_uncertainty_score":0.0029556751},"labels":[],"label_agreement":null},{"id":"W4401728325","doi":"10.1097/cad.0000000000001658","title":"Screening of a kinase inhibitor library identified novel targetable kinase pathways in triple-negative breast cancer","year":2024,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium","funders":"Ontario Genomics Institute; National Cancer Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Ontario Genomics; Genome Canada; McGill University; Genentech; Bayer; Tulane University; Pfizer; Bristol-Myers Squibb","keywords":"Kinome; Cyclin-dependent kinase 4; Triple-negative breast cancer; Cancer research; Kinase; Cyclin-dependent kinase; Cyclin-dependent kinase 7; Biology; Cyclin-dependent kinase 2; Cyclin-dependent kinase 9; Cancer; Cell biology; Cell cycle; Breast cancer; Protein kinase A; Genetics","score_opus":0.018259640537071277,"score_gpt":0.2670174725904091,"score_spread":0.24875783205333782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401728325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686765,0.009409368,0.006463708,0.0003242876,0.00005945102,0.0006070253,0.0062858765,0.00041881352,0.0077548334],"genre_scores_gemma":[0.9616858,0.011553144,0.0093383,0.0002942766,0.000022748492,0.0002506649,0.01025664,0.00004603199,0.006552456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998667,0.000014722034,0.0000109577995,0.000030096715,0.000049975188,0.000027481256],"domain_scores_gemma":[0.9999366,0.00001613903,0.000011087551,0.0000062663244,0.000014341818,0.000015588024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017517207,0.00057345943,0.00079356274,0.00094559515,0.00024808766,0.0004170408,0.00029256172,0.00027017583,0.0023349859],"category_scores_gemma":[0.00018936499,0.00020033601,0.00038913617,0.00079464185,0.00016047632,0.00021720865,0.00026222033,0.0004423983,0.00061507284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042851313,0.00045279972,0.0012589374,0.00039506797,0.0000780938,0.0005038344,0.000040639716,0.0017381458,0.96631014,0.00028538785,0.00075493404,0.027753554],"study_design_scores_gemma":[0.00037539468,0.0061681787,0.019303482,0.00012291175,0.0005026125,0.00261499,0.00011970779,0.0052720853,0.940885,0.00027840937,0.024303699,0.000053566047],"about_ca_topic_score_codex":0.0008167353,"about_ca_topic_score_gemma":0.0027458838,"teacher_disagreement_score":0.0023349859,"about_ca_system_score_codex":0.00034422058,"about_ca_system_score_gemma":0.00050775486,"threshold_uncertainty_score":0.007811308},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"}]}